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“But so that life may in some measure be restored to the animal, you must attempt an opening in the 
trunk of the trachea and pass into it a tube of rush or reed, and you must blow into this so that the 
lung may expand and the animal draw breath after a fashion; for at a light breath the lung in this 
living animal will swell to the size of the cavity of the thorax, and the heart take strength afresh and 
exhibit a great variety of motions”. 
This translation from the original Latin text is the first account of mechanical ventilation. The 
experiment was performed on a pregnant sow by Andreas Vesalius and reported in the last 
chapter of his famed anatomical treatise “De humani coporis fabrica” published in 1543.
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Voor mijn moeder

Contents
Chapter 1 General Introduction.
Netherlands Journal of Medicine. 2005; 63(10): 382-392.
9
Chapter 2 Mechanical ventilation in healthy mice induces reversible pulmonary 
and systemic cytokine elevation with preserved alveolar integrity: An 
in-vivo model using clinical relevant ventilation settings.
Anesthesiology. 2007; 107(3): 419-426.
25
Chapter 3 Low tidal volume mechanical ventilation induces a Toll-like receptor 4 
dependent inflammatory response in healthy mice.
Anesthesiology. 2008; 109(3): 465-472.
41
Chapter 4 Mechanical ventilation induces a Toll/interleukin-1 receptor domain-
containing adapter inducing interferon-beta dependent inflammatory 
response in healthy mice.
Anesthesiology. In press.
59
Chapter 5 Hypercapnic acidosis attenuates the pulmonary innate immune 
response in ventilated healthy mice.
Critical Care Medicine. 2008; 36(8): 2403-2406.
75
Chapter 6 Isoflurane attenuates pulmonary IL-1β and systemic TNF-α following 
mechanical ventilation in healthy mice.
Acta Anaesthesiologica Scandinavica. 2009; 53(6): 742-748.
87
Chapter 7 General discussion 101
Chapter 8 Summary 111
Chapter 9 Samenvatting 115
Chapter 10 Dankwoord 119
Curriculum Vitae 123
List of Publications 125

Chapter 1
General Introduction
Adapted from
Cytokines and Biotrauma in Ventilator Induced Lung Injury: 
 a critical review of the literature .
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Netherlands Journal of Medicine. 
2005; 63(10): 382-392.
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HIstorICaL oVerVIew
In 1745, John Fothergill presented the first interesting case report addressing the issue of lung 
injury induced by artificial respiration.1 The case involved an apneic, pulseless individual who 
had collapsed due to noxious fumes from a coal pit. As described by Fothergill, a physician by 
the name of Tossack applied his mouth close to the patient, and by blowing strongly, pulling 
the nostrils at the same time, raised his chest fully by his breath. Immediately six or seven very 
quick beats of the heart were felt, the thorax movement continued and a pulse was soon felt in 
the arteries. Within one hour, the patient began to come round and walked home within four 
hours and after a couple of days returned to work. Fothergill suggested that mouth-to-mouth 
resuscitation may be better than using a mechanical method of insufflating the lungs with air 
using a pair of bellows because “the lungs of one man may bear, without injury, as great a force 
as those of another man can exert; which by the bellows cannot always be determined”. Thus, 
Fothergill had an early understanding of the concept of ventilator induced lung injury (VILI).
The age of widespread mechanical ventilation began after the introduction of the whole 
body negative pressure device, tank respirator (figure 1). The device was a large, airtight metal 
cylinder that enclosed the patient, exposing only the head and neck. Negative pressure was 
generated with an electric pump, causing the patient’s chest to rise. This device was particularly 
effective as a noninvasive form of mechanical ventilation for patients with normal airways and 
it was extensively used in the mid-1950s during the poliomyelitis epidemic. However after the 
introduction of repeated blood gas analysis it was found that negative pressure ventilation 
failed to provide adequate ventilation. Positive pressure ventilation with the use of an artificial 
airway replaced the negative pressure support technology. Soon different modes of positive 
Figure 1: Iron lung
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pressure ventilation were introduced and the modern era of respiratory support was born 
including controlled mechanical ventilation and assisted ventilation.
In 1974, Webb en Tierney demonstrated that mechanical ventilation with high peak airway 
pressures resulted in the development of a pressure gradient between an alveolus and the adja-
cent bronchovascular sheath, causing lung edema, alveolar disruption and air leakage.2 This has 
been termed “barotrauma”. The clinical and radiological manifestations of “barotrauma” include 
pneumothorax, pneumomediastinum, pneumoperitoneum and subcutaneous emphysema.3;4 
Soon studies investigated the physical forces and challenged the concept of “barotrauma”. For 
example, mechanical ventilation of rabbits with high peak inspiratory pressures (45 cm H2O) 
resulted in severe pulmonary edema and gross lung injury. In contrast, in rabbits encased in 
plaster casts, ventilation with similar airway pressures resulted in less lung injury.5 Thus alveolar 
overdistension and not the end-inspiratory pressure per se was hypothesized as the main 
determinant.6 Accordingly, the term “volutrauma” was introduced.
Subsequent studies showed that cyclic opening and collapsing of alveoli, even at low inspi-
ratory pressures and low inspiratory volumes, increased stretch- and shear forces resulting in 
lung injury and surfactant dysfunction.7;8 This “atelectrauma” could be attenuated by increasing 
Positive End-Expiratory Pressure (PEEP) and outweighed the concomitant increase in inspira-
tory pressure.2;9
Although little doubt exists that mechanical ventilation (especially at high volume) can 
physically disrupt the lung, recent studies have shown that mechanical ventilation also results 
in more subtle morphological and functional changes and can excite an inflammatory response 
within the lung, a mechanism called “biotrauma”.10-12 Figure 2 shows a historical overview of 
mechanical ventilation-induced lung injury.
VentILator InduCed LunG Injury
Clinical aspects:
Mechanical ventilation is one of the cornerstones of treatment in the intensive care unit. Despite 
its lifesaving effects, mechanical ventilation may lead to serious damage in both previously 
healthy and diseased lungs.2;6;10;11;13;14 In its most severe form VILI can result in Acute Respira-
tory Distress Syndrome (ARDS). The diagnostic criteria for ARDS include: acute onset; bilateral 
chest infiltrates; pulmonary artery occlusion pressure of 18 mm Hg or less or no evidence of left 
atrial hypertension; impaired oxygenation regardless of the level of PEEP with a ratio of partial 
pressure of oxygen in arterial blood (PaO2) to fractional intake of oxygen (FiO2) of less than 
200.15 In short, the syndrome is characterized by leaky, stiff lungs and severe hypoxemia, associ-
ated with inflammatory alveolar fluids.15 The reported mortality of ARDS is still 30 to 50%.15-19 
Interestingly, most patients with ARDS do not die from respiratory failure but from multiple 
organ dysfunction syndrome (MODS).20 Why would a patient having a disease that primarily 
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affects the lungs eventually die from distal organ failure? One challenging hypothesis is that 
the inflammatory response originating from the lungs “spreads out” and triggers a systemic 
inflammatory response. Indeed, several studies have found that mechanical ventilation is asso-
ciated with a systemic inflammatory response. Moreover, ventilator settings, especially tidal 
volume, have been shown to affect the severity of the inflammatory response.13;21-23 In patients 
with ARDS the highest cytokine concentrations are found downstream from the lung,24 sup-
porting the notion that biotrauma is not only confined to the lungs.3;3;10-12;21;25;25;25-31 Although 
studies have shown an association between pulmonary and systemic inflammatory mediators 
and outcome in ARDS patients,13 a causal relationship has not been proven. Nevertheless, a 
more in depth insight into the inflammatory pathways associated with mechanical ventilation 
may prove valuable in developing therapeutic strategies to limit inflammation in mechanically 
ventilated patients.
Cytokines:
Cytokines are low-molecular weight soluble proteins that transmit signals between cells 
involved in the inflammatory response.32 In the lung, cytokines originate from bronchial, 
bronchiolar and alveolar epithelial cells,33;34 alveolar macrophages and neutrophils.35 It is now 
commonly accepted that increased production of cytokines in the lung plays a key role in VILI.36 
Figure 2: Historical overview of mechanical ventilation-induced lung injury.
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Several mechanisms have been proposed to initiate the enhanced generation of cytokines with 
mechanical ventilation including alterations in cytoskeletal structure without ultrastructural 
damage (mechanotransduction),37;38 stress failure of the alveolar barrier (decompartimental-
ization),39 stress failure of the plasma membrane (necrosis),40 and effects on the pulmonary 
vasculature independent of stretch or rupture.10
To examine the mechanisms of cytokine generation during mechanical ventilation, in-vitro, 
ex-vivo and in-vivo models, have been studied.36 Upon stretch, alveolar cells produce inflamma-
tory mediators such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, IL-8, IL-10,34;35;41-45 
in vitro,34;35;44;46. Ventilation with large tidal volume results in a similar inflammatory response 
both ex-vivo,47 and in-vivo.12;39;48;49
Clinical studies have shown that the inflammatory response in the lung depends on ventila-
tor settings. Transiently increasing tidal volume from 5 to 12 ml/kg and reducing PEEP from 
15 to 5 cmH2O in acute lung injury patients, increases levels of IL-6, IL-10 and TNF-α levels 
in both broncho-alveolar lavage (BAL) fluid and plasma within one hour.13;50 These findings 
are consistent with the results of Ranieri et al., reporting lower cytokine levels in BAL fluid of 
patients ventilated with low tidal volume,21 and those of the ARDS network trial that found 
lower plasma IL-6 levels in the low tidal volume group.13
Despite the fact that low tidal volume ventilation ameliorates the inflammatory response, 
subjects are still in a “pro-inflammatory state” during mechanical ventilation. It should be noted 
that we do not yet know the ventilatory strategy that is the most effective in limiting inflam-
mation.
Leukocytes:
The activation and attraction of leukocytes to the lungs is an important feature in VILI.51-53 
Under normal conditions leukocytes must undergo a considerable change in shape to squeeze 
through the small pulmonary capillaries, which increases transit time, creating a “physiological 
sink” of leukocytes in the lung.54 Therefore a large pool of leukocytes, which is available at all 
times, exists in the lung. Leukocytes are predominantly activated and attracted to the lungs 
by chemokines.53 Keratinocyte-derived chemokine (KC; IL-8 homologue) is the most potent 
leukocyte attractant.55 Experimental leukocyte depletion is associated with dampened KC 
response in the lungs of animals.51;52 Moreover, leukocyte depletion significantly reduces VILI 
as indicated by improved gas exchange and reduced pulmonary protein leak compared to 
non depleted animals. 51 Interestingly, alveolar recruitment of leukocytes by instilling a chemo 
attractant does not result in lung injury,56 indicating that other mediators, possibly cytokines, 
are necessary to activate the leukocytes.
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Role for Toll-like receptors:
The Toll-like receptors owe their name to the closely related receptor called Toll, first identified 
in Drosophila in 1988 during a screen for polarity in early embryogenesis.57 Subsequently, it 
was shown that Toll gene mutant flies are highly susceptible to fungal infection, demonstrating 
that Toll is an important receptor in the innate immune system for detecting the invasion of 
microorganisms.58 Since 1997, mammalian homologues of the Toll receptor were identified and 
designated as Toll-like receptors (TLRs). TLRs in mammals have been a major focus for research 
in immunology. To date, 11 human TLRs and 13 mouse TLRs have been identified.59 TLRs appear 
to act as primary sensors by virtue of their capacity to recognize various microbes and initiate 
an immune response.60-63 TLR expression is not restricted to immunological cells, but has also 
been found in lung tissue.
Interestingly, more recent data demonstrated that TLRs not only recognize microbial prod-
ucts, but also endogenous ligands. These ligands have been called ‘danger signals’.64;65
Most research on lung injury has focused on TLR2 and TLR4. Activation of TLR4 with lipo-
polysaccharide induces a pro-inflammatory response.66;67 Lipopolysaccharide is a component 
of the outer membrane of Gram-negative bacteria. After binding to TLR4,68 it induces an intense 
inflammatory response associated with lung injury.69-71
Lung injury induced by hemorrhage,72-74 ischaemic-reperfusion,75 contusion,76 hyperoxia or 
administration of bleomycin,77 results in an inflammatory response that is also mediated via 
TLR4 and/or TLR2 supporting a role for these receptors in the development of non-infectious 
lung-injury. Endogenous ligands for TLR4 and TLR2 have now been identified and include heat 
shock protein 60,78 fibronectin,79 heparan sulfate proteoglycan,80 biglycan,81 hyaluronan82 and 
the myeloid-related proteins 8 and 14.83
Downstream signaling of TLRs is complex (figure 3). Briefly, TLR signaling is initiated by 
the Toll/interleukin-1 receptor (TIR domain),84 and mediated through a TIR domain contain-
ing adaptor protein: myeloid differentiation factor 88 (MyD88).85 MyD88 is a critical adaptor 
molecule used by all TLRs.86 In TLR4 an alternative, MyD88 independent pathway, was also 
identified. This pathway is mediated through a TIR domain containing adaptor called TRIF (Toll/
interleukin-1 receptor domain-containing adapter inducing interferon-b). In TLR4 signaling 
TRIF as well as MyD88 activates nuclear factor-kB (NF-kB),59 a DNA binding protein that plays 
a central role as a common messenger in cytokine regulation and inflammation. NF-kB activa-
tion is a critical step in the transcription of genes necessary to perpetuate the innate immune 
response, a process that starts within minutes after commencing mechanical ventilation.87 In 
an experimental model the inflammatory response following high tidal volume ventilation was 
mediated by NF-kB,47 and blockage of NF-κB decreased VILI.11;35;47;52;88 As TLR4 and 2 have been 
shown to mediate non-infectious lung injury,77 they are potential targets for the treatment of 
VILI, although no studies have proven this concept so far.
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ModuLatInG tHe InfLaMMatory resPonse foLLowInG MeCHanICaL 
VentILatIon
Protective ventilation:
Mechanical ventilation-induced inflammation is associated with lung injury,13 and peripheral 
organ dysfunction.27 Furthermore, persistent cytokine elevation is associated with a poor out-
come in patients with ARDS.89;90 Therefore strategies to reduce mechanical ventilation-induced 
inflammation may be of clinical relevance. Low tidal volume mechanical ventilation was 
designed to protect the lungs from excessive stretch. This so called “lung protective mechanical 
ventilation” attenuates inflammation in patients with acute lung injury.21;22 Furthermore the 
ARDS network study in 2000,13 showed improved survival in these patients after treatment with 
low tidal volume mechanical ventilation. Despite these improvements no definitive treatment 
for ARDS has been found.
Hypercapnia:
Permissive hypercapnia (deliberate induction of alveolar hypoventilation and acceptance of 
hypercapnia) is a therapeutic approach designed to maintain oxygenation while preventing 
the risks caused by excessive airway pressures. Severe hypercapnic acidosis is usually well 
tolerated,91 and one clinical study suggest a protective effect on various organs, including the 
lung.92;93 A retrospective multi-variate logistic regression analysis of the ARDS network trial 
suggests that hypercapnic acidosis may be protective in ARDS patients ventilated with high 
tidal volumes.94 An increase in carbon dioxide may have a direct modulating effect on the 
inflammatory response. Therefore hypercapnic acidosis is a strategy worth testing in clinical 
trials that aim to reduce VILI.
Isoflurane:
Isoflurane is widely used as a general inhalation anesthetic. It has profound protective immu-
nological effects on the heart,95 the brain,96 and the kidneys.97 In lung tissue, isoflurane was 
found to inhibit cytokine production in an in vitro model stimulating alveolar epithelial type II 
cells.98;99 In vivo models also show isoflurane to reduce inflammation in endotoxin induced 
lung injury,100;101 Therefore patients who need to be mechanically ventilated may benefit from 
the anti-inflammatory effects of isoflurane on cytokine release. Surprisingly, the effects of iso-
flurane on mechanical ventilation-induced pulmonary and systemic inflammation in healthy 
lungs has not been studied.
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aIM of tHIs tHesIs
Mechanical ventilation is associated with serious adverse effects. The injury caused by mechani-
cal ventilation extends beyond the lungs and thus may be a major factor contributing to patient 
morbidity and mortality. Unravelling the inflammatory pathways activated by mechanical 
ventilation and investigating strategies to modulate this inflammatory response are the main 
aims of this thesis.
In chapter 2 the effect of mechanical ventilation on inflammatory parameters in healthy 
animals was studied. Evidence is accumulating that mechanical ventilation can be the sole 
trigger for lung injury. An animal model was therefore developed using ventilatory protocols 
analogous to those currently used in clinical practice. To investigate whether mechanical venti-
lation alone can induce an inflammatory response without evoking histopathological damage, 
healthy C57BL6 mice were mechanically ventilated for up to four hours.
Figure 3: Dowstream signaling of Toll like receptors 
Reprinted with permission from K. Takeda and S. Akira. / Seminars in Immunology 2004
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In chapter 3 the mechanism underlying the inflammatory response following mechanical 
ventilation in the healthy lung was analyzed. TLR4 and TLR2 have been shown to mediate non-
infectious lung injury, and might also be important in the development of VILI. We therefore 
investigated the role of TLR4 and TLR2 receptor signaling in the mechanical ventilation-induced 
inflammatory response in wild type, TLR4 knock out and TLR2 knock out mice. In addition, we 
searched for the presence of endogenous ligands for TLR4 in the lungs of these animals.
In chapter 4, the activation of the pathway downstream of TLRs following mechanical ventila-
tion in the healthy lung was studied. TRIF acts downstream of TLR3 and 4 (figure 3) and has 
been identified as the key signaling pathway in acid induced lung injury. We mechanically 
ventilated wild type- and TRIF mutant mice to investigate the role of the TRIF pathway in the 
inflammatory response following mechanical ventilation.
Predominantly protective but also harmful effects of hypercapnia have been reported in 
experimental studies. In chapter 5 the effect of hypercapnic acidosis on mechanical ventilation-
induced inflammation in healthy lungs was investigated. Mice were mechanically ventilated 
using different inspiratory fractions of carbon dioxide.
Isoflurane is widely used in general anesthesia and has profound protective immunological 
effects on different organs, including the lung. In chapter 6 the effect of isoflurane on the 
inflammatory response induced by mechanical ventilation in the healthy mouse lung was 
studied. Mechanically ventilated mice received different inspiratory concentrations of isoflu-
rane during ventilation.
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Mechanical ventilation in healthy mice induces 
reversible pulmonary and systemic cytokine 
elevation with preserved alveolar integrity:
An in-vivo model using clinical relevant ventilation settings
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abstraCt
Background:
Mechanical ventilation (MV) may activate the innate immune system, causing the release of 
cytokines. The resulting pro-inflammatory state is a risk factor for ventilator-induced lung injury. 
Cytokine increase results from direct cellular injury, but may also result from cyclic stretch alone 
as demonstrated in-vitro: mechanotransduction. To study mechanotransduction in-vivo, the 
authors used an animal MV model with clinically relevant ventilator settings, avoiding alveolar 
damage.
Methods:
Healthy C57BL6 mice (n=82) were ventilated (tidal volume, 8 ml/kg; positive end-expiratory 
pressure, 4 cm H2O; fraction of inspired oxygen, 0.4) for 30, 60, 120 and 240 min. Assigned 
animals were allowed to recover 2 days after MV. Both pulmonary tissue and plasma interleukin 
(IL)-1a, IL-1b, tumor necrosis factor a, IL-6, IL-10, and keratinocyte-derived chemokine levels 
were measured. Histopathologic appearance of lung tissue was analyzed by light microscopy 
and electron microscopy.
Results:
In lung tissue, all measured cytokines and keratinocyte-derived chemokine levels increased 
progressively with MV duration. Light microscopy showed increased leukocyte influx but no 
signs of alveolar leakage or albumin deposition. Electron microscopy revealed intact epithelial 
cell and basement membranes with sporadically minimal signs of partial endothelial detach-
ment. In plasma increased levels of IL-1a, tumor necrosis factor a, IL-6, and keratinocyte-derived 
chemokine were measured after MV. In the recovery animals, cytokine levels had normalized 
and no histologic alterations could be found.
Conclusions:
Mechanical ventilation induces reversible cytokine increase and leukocyte influx with preserved 
tissue integrity. This model offers opportunities to study the pathophysiological mechanisms 
behind ventilator-induced lung injury and the contribution of MV to the “multiple hit” concept.
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IntroduCtIon
Mechanical ventilation (MV) is widely used in general anesthesia and is a lifesaving intervention 
in critically ill patients. It can, however, induce lung injury in the healthy lung or exacerbate 
damage in the already injured lung. This has been termed ventilator-induced lung injury (VILI).1;2 
Clinical studies show that the use of large tidal volumes (VT ≥ 12 -15 ml/kg) is associated with 
a poor prognosis; however, a “lung-protective ventilation strategy” (low tidal volumes [VT < 
10 – 12 ml/kg], optimizing positive end-expiratory pressure [PEEP]) reduces but cannot prevent 
VILI.1;3-8 VILI is characterized by the release of inflammatory mediators (especially cytokines), 
infiltration of leukocytes, alveolar and interstitial edema, alveolar protein deposition, cellular 
necrosis, and tissue disruption.9;10 It is now commonly accepted that increased production of 
cytokines, especially interleukin (IL)-1b, IL-6, IL-8, and tumor necrosis factor (TNF)-a, plays a key 
role in initiating or perpetuating lung injury.11-17
The clinical relevance of cytokine up-regulation by MV is the resulting proinflammatory state, 
because this makes the host more vulnerable to a “second hit” (e.g., major surgery).18 To note, 
MV itself can be the ”second hit” where an already comprised host exists (e.g., MV in the critically 
ill patient).3;4;19
Two mechanisms are believed to be responsible for MV-induced cytokine release. The first is 
direct trauma to the cell with disruption of the membranes, resulting in translocation of cyto-
kines into both the alveolar space and the systemic circulation. This “decompartmentalization” 
has been demonstrated in-vivo.13;20;21 The second has been termed mechanotransduction. In 
vitro studies show that most pulmonary cells, such as alveolar macrophages, epithelial cells, 
and endothelial cells, can produce cytokines in response to cyclic stretch.22-24 However, the 
sensing mechanism of these physical forces and the translation into intracellular signals is 
largely unknown.25
In many of the currently available experimental VILI models, injurious MV settings (e.g., VT > 
25 ml/kg or peak pressures > 20-40 cm H2O) have been used in healthy animals,
11;12;14;26;27 or 
the “multiple-hit” model was used by applying MV in already injured animals.13;15;16;28;29 From 
these study designs, it is not possible to differentiate whether the observed increase in cytokine 
levels is the result of decompartmentalization, mechanotransduction, or both.
For a better understanding of the relevant pathophysiological mechanisms leading to VILI, it 
is important to study in vivo the effects of ventilation in the healthy lung, using ventilatory pro-
tocols analogous to those currently used during general anesthesia and in the intensive care 
unit patient. We studied the effects of MV in healthy mice, carefully searched for pulmonary cell 
or tissue disruption, counted leukocyte numbers and measured cytokine production in lung 
tissue and plasma.
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MaterIaL and MetHods
All experiments were approved by the Regional Animal Ethics Committee in Nijmegen, The 
Netherlands, and performed under the guidelines of the Dutch Council for Animal Care and the 
National Institutes of Health.
Animals:
Experiments were performed in male C57BL6 mice (n = 82; Charles River, Sulzfeld, Germany) 
aged 10 - 12 weeks, with weights ranging from 23 to 28 g.
Mechanical Ventilation in mice:
Mice were anesthetized with an intraperitoneal injection of a combination of ketamine, 
medetomidine and atropine (KMA): 7.5 μl per gram of body weight of induction KMA mix (con-
sisting of 1.26 ml ketamine, 100 mg/ml; 0.2 ml medetomidine, 1 mg/ml; 1 ml atropine, 0.5 mg/
ml; and 5 ml NaCl 0.9%) was given just before intubation. Animals were orally intubated under 
direct vision with an endotracheal tube (0.82 mm ID, 1.1 mm OD, length 25 mm). Endotracheal 
tube position was confirmed by end-tidal carbon dioxide analysis, using mass-spectrometry. 
Subsequently animals were connected to the ventilator (MiniVent®, Hugo Sachs Elektronik-
Harvard apparatus, March-Hugstetten, Germany). VT was set at 8 ml/kg and frequency at 150/
min, which is well within the range of measured VT and respiratory rate during spontaneous 
ventilation in C57BL6 mice.30 All animals received 4 cm H2O PEEP. To avoid direct oxygen toxi-
city, as reported by several authors,31;32 the fraction of inspired oxygen (FiO2) was set at 0.4.
To maintain anesthesia, 5.0 μl per gram of body weight boluses of maintenance KMA mix 
(consisting of 0.72 ml ketamine, 100 mg/ml; 0.08 ml medetomidine, 1 mg/ml; 0.3 ml atropine, 
0.5 mg/ml; and 18.9 ml NaCl 0.9%) were given, via an intraperitoneally placed catheter, every 30 
min. Throughout the experiment rectal temperature was monitored and maintained between 
36º and 37.5ºC using a heating pad.
Study groups:
Animals were divided into seven groups. Group C (n = 9) served as control group: after induction 
of anesthesia, these mice were killed immediately, without being ventilated. Animals in groups 
30 (n = 6), 60 (n = 6), 120 (n = 9), 240 (n = 9), were ventilated for 30, 60, 120 and 240 min, respec-
tively, and were killed immediately thereafter. In group R (recovery group), animals (n = 6) were 
extubated after being ventilated for 240 min and sacrificed after two days recovery. Anesthesia 
was discontinued in the group R animals 1 h before extubation. Group D (depleted group) 
animals (n = 6) were first leukocyte depleted by administering cyclophosphamide as described 
earlier.33;34 These animals were then ventilated for 240 min and killed immediately thereafter.
A separate set of experiments (IABP group, n = 15) was conducted to assess if the chosen 
anesthetic and ventilation regime resulted in a stable and reproducible cardiorespiratory 
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condition. In these animals continuous intraarterial carotid blood pressure was measured. Arte-
rial blood gas analysis was performed after 120 min (n=6) and 240 min (n=9). The same ventila-
tor settings were used as for the mice in the aforementioned groups. We decided not to include 
the animals from the IABP group for the cytokine or histopathologic analysis to avoid possible 
interference with cytokine response resulting from instrumentation induced tissue damage.
In addition two control experiments were performed. In the first control experiment, ani-
mals (n=12) received the standard ventilation strategy (VT, 8 ml/kg; PEEP, 4 cm H2O; FiO2 0.4). 
The lungs were removed after 0 min (n = 4, control), 120 min (n = 4) and 240 min (n = 4) of MV to 
measure wet/dry ratios. In the second control experiment animals (n = 4) were ventilated with a 
VT of 16 ml/kg, PEEP of 4 cm H2O and FiO2 of 0.4 for 240 min. The lungs of these mice were used 
to histopathologically asses the effects of high-VT ventilation in our model.
Material harvesting:
After the animals were killed, blood was collected by exsanguination, centrifuged at 14,000 rpm 
(13,000 g) (Eppendorf 5415 C, Nethler-Hinz GmbH, Hamburg, Germany) for 2 min and plasma 
was stored at - 80°C. Immediately after exsanguination, the heart and lungs were carefully 
removed en block via midline sternotomy. The right middle lobe was fixed for light microscopy 
(LM) and electron microscopy (EM), except in animals analyzed for wet/dry ratio. The remaining 
lung tissue was homogenized for the determination of cytokine concentrations.
Preparation and analysis of lung tissue:
For LM the material was fixed in 4% buffered formalin solution overnight at room temperature, 
dehydrated, and embedded in paraplast (Amstelstad, Amsterdam, The Netherlands). Sections 
of 4 μm-thickness were used for further analysis. The enzyme activity of leukocytes was visual-
ized by enzyme histochemistry using chloracetatesterase staining (Leder). Periodic acid-Schiff 
staining was performed to analyze for alveolar albumin presence. Leukocytes were counted 
manually (20 fields per mouse), and after automated correction for air/tissue ratio, leukocytes 
per μm2 were calculated.
For EM the material was fixed in 2.5% glutaraldehyde dissolved in 0.1 M sodium cacodyl-
ate buffer, pH 7.4, overnight at 4°C and washed in the same buffer. The tissue fragments were 
postfixed in cacodylate-buffered 1% OsO4 for 120 min, dehydrated, and embedded in Epon 
812 (Merck, Darmstadt, Germany). Ultrathin sections were cut on an Ultratome (Leica, Reichert 
Ultracuts, Vienna, Austria), and contrasted with 4% uranyl acetate for 45 min and subsequently 
with lead citrate for 4 min at room temperature. Sections were examined in a Jeol 1200 EX2 
electron microscope (JEOL, Tokyo, Japan). The evaluating pathologist was blinded for the group 
and ventilation protocol to which the animal had been assigned.
For wet/dry ratios, both lungs were used; ratios were calculated by measuring lung weight 
before and after heating for 24 hours in a stove at 50ºC.
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Laboratory tests:
IL-1a and IL-1b were assessed using specific radioimmunoassays, as described previously.35 Levels 
of TNF-a, IL-6, IL-10, and keratinocyte-derived chemokine (KC) in lung homogenate and plasma 
were measured using enzyme-linked immunosorbent assay (for TNF-a, IL-6 and IL-10: CytoSet, 
BioSource, Camarillo, CA; for KC: ELISA-Kit, R&D Systems, Minneapolis, MN). Lower detection 
limits were as follows: IL-1a and IL-1b: 40 pg/ml; TNF-a: 32 pg/ml; IL-6: 160 pg/ml; IL-10: 16 pg/ml; 
and KC: 160 pg/ml. For the assessment of KC in plasma in group 60 insufficient plasma was avail-
able; the plasma had to be diluted for analysis which increased the detection limit to 1,600 pg/
ml. To investigate whether lipopolysaccharide contamination was present in our experimental 
setting we measured lipopolysaccharide in air, tubing, and the ventilator by Limulus Amebocyte 
Lysate testing (Cambrex Bio Science, Walkersville, MD; detection limit: 0.06 IU/ml).
Statistical Analysis:
Data are expressed as means (SD) when distributed normally (leukocyte counts and wet/dry 
ratios) and expressed as median (range) otherwise (cytokine concentrations). Statistical analysis 
was performed with SAS (SAS Institute Inc. Cary NC) statistical procedures. Because cytokine 
concentrations are not normally distributed, Kruskal-Wallis procedures were used, with post hoc 
comparisons of subgroups (Duncan). Data of a particular cytokine concentration variable were 
ranked, followed by analysis of variance in the General Linear Models procedure using the MEANS 
procedure with the Duncan option and Bonferroni correction for multiple comparisons. For the 
analysis of leukocyte counts and wet/dry ratios analysis of variance was used on non-ranked data 
with post hoc comparison of group means (Duncan). The level of significance was set at P < 0.05.
resuLts
Cardiorespiratory Parameters:
The animals with an intraarterial canula (IABP-group) exhibited stable hemodynamic parame-
ters throughout the experiments. Mean arterial pressure was within normal limits and remained 
above 65 mmHg in all animals. Blood gas analysis showed normal pH, arterial carbon dioxide 
tension (PaCO2) and arterial oxygen tension (PaO2) levels with a small decrease in base excess 
(table 1). Two of six animals in group R (recovery group) died directly after extubation. Before 
extubation these animals did not differ from surviving subjects in cardiorespiratory parameters. 
The remaining four animals were stable during the ventilation free interval, with normal activity 
and behavior and no respiratory distress or weight loss.
Histological Examination:
Electron microscopy examination of the lung tissue from animals in groups 30, 60, 120, and 240 
revealed intact basement membranes and no signs of alveolar flooding. Type I pneumocytes 
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sporadically showed signs of minimal membrane disruption and small partial detachment of 
endothelium (figs. 1A and B). Animals that were allowed to recover (group R) and unventilated 
animals (group C) showed no signs of membrane disruption or detachment of endothelium 
(fig. 1C). The four animals in the control experiment that were ventilated with a VT of 16 ml/kg 
Table 1. Intraarterial Blood Pressure and Arterial Blood Gas Analysis during Mechanical Ventilation
Blood Gas Values
Duration of 
MV, min
MAP, 
mmHg
pH PaO2
(mmHg)
PaCO2
(mmHg)
HCO3
(mmol/l)
BE
0 102 (10)
60 89 (12)
120 83 (14) 7.36 (0.06) 229 (50) 38 (7) 20.4 (1.2) -4.4 (1.5)
180 78 (6)
240 79 (8) 7.35 (0.07) 194 (50) 36 (8) 19.6 (3.1) -6.3 (2.0)
Values are mean (SD).
BE = base excess; MAP = mean arterial pressure; MV = mechanical ventilation; PaCO2 = arterial carbon 
dioxide tension; PaO2 = arterial oxygen tension. 
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Fig 1. Electron microscopy.
(A and B) Lung tissue of healthy animals after 240 min of mechanical ventilation. B is a magnification of 
a section of A (see dotted rectangle). Mostly the membrane of type I pneumocyte stayed intact (black 
arrowhead, B); sporadically, signs of membrane disruption and partial detachment of endothelium 
occurred (black arrow, B). Animals that were allowed to recover for two days (group R) and unventilated 
healthy control animals (group C) showed no signs of membrane disruption and no detachment of 
endothelium (C). Animals ventilated with tidal volume of 16 ml/kg showed extensive damage with lungs 
appearing overinflated with loss of septal walls (black arrowheads, D) and injury of type I pneumocyte and 
endothelium (inset, D). Magnification: A and C: 5,000x; B: 15,000x; D: 3,000x (inset 7,000x). E = erythrocyte; 
L = leukocyte; PI = type I pneumocyte; PII = type II pneumocyte.
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showed significant injury; lungs appeared overinflated (airtrapping) with loss of septal walls 
and injury of type I pneumocyte (fig. 1D).
Light microscopy examination using periodic acid-Schiff staining showed no intraalveolar 
albumin. Leder staining revealed a substantially higher number of pulmonary leukocytes after 
120 and 240 min of MV (fig. 2). No differences in leukocyte counts were found in the animals 
that were allowed to recover (group R) compared with the unventilated animals (group C).
Wet/dry ratios showed increased ratios only after 240 min of MV. Data are presented in table 2.
A B C
D E F
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D E F
Fig. 2: Light microscopy.
Light microscopy examination of lung tissue after Leder staining revealed a significantly higher number 
of pulmonary leukocytes in healthy animals after 120 (group 120, D) and 240 min (group 240, E) of 
mechanical ventilation compared with the unventilated control animals (group C, A). Significantly lower 
numbers of pulmonary leukocytes were found in the animals that were allowed to recover (group R, 
F) compared with animals ventilated for 240 min (group 240, E). No differences were found between 
unventilated controls (group C, A) and the animals that were allowed to recover (group R, F). For the 
results of leukocyte counts, see table 2. (A) Unventilated control animals. (B-E) Healthy animals receiving 
mechanical ventilation for 30, 60, 120 and 240 min. (F) Animals that were allowed to recover for 2 days 
after being ventilated for 240 min (group R). Magnification: 750x.
Table 2. Leukocyte Counts and Wet/Dry Ratios
Groups Leukocytes x 10-4 / μm2, 
Mean (SD)
 P value Wet/Dry Ratio, Mean (SD) P value
Control 2.1 (1.3) 4.68 (0.014)
“30” 2.4 (1.6) NS
“60” 2.2 (2.2) NS
“120” 9.7 (5.0) <0.05 4.81 (0.13) NS
“240” 5.7 (3.1) <0.05 5.01 (0.06) <0.05
Recovery 1.2 (0.9)  <0.05*
Values are mean (SD).
P values compared with Control group (unventilated animals). * P value compared to group 240 (240 min 
of ventilation).
NS = not significant.
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Cytokine Concentration Induced by Mechanical Ventilation:
Mechanical ventilation with a VT of 8 ml/kg, PEEP of 4 cm H2O and FiO2 of 0.4 resulted in a 
significant increase in IL-1a, IL-1b, TNF-a, IL-6, IL-10, and KC in lung tissue homogenate when 
compared with unventilated animals (group C). These cytokine concentrations increased with 
the duration of MV, with KC being the first to increase from 30 min of MV onwards. IL-1b, TNF-a, 
IL-6 and IL-10 levels increased after 60 min, while IL-1a increased after 240 min compared with 
group C animals (fig. 3).
Fig. 3: Cytokine levels in lung tissue homogenate.
Mechanical ventilation significantly increased levels of interleukin (IL)-1a, IL-1b, tumor necrosis factor 
(TNF)-a, IL-6, IL-10 and keratinocyte-derived chemokine (KC) in lung tissue homogenate compared with 
unventilated animals (group C). When animals were allowed to recover for 2 days (group R), all lung tissue 
cytokine levels were found to be lower when compared with levels found in animals killed immediately 
after 240 min of ventilation (group 240). IL-1a and KC levels in group R animals were higher compared 
with group C animals. In leukocyte-depleted animals (group D), mechanical ventilation resulted in 
significantly higher levels of lung tissue IL-1a, IL-6, IL-10 and KC compared with group C animals. IL-1b, 
TNF-a and KC levels were lower compared with the levels found after 240 minutes of MV in healthy 
animals (group 240). Data are expressed as box (median, 25th and 75th percentiles) and whiskers (range). 
* P < 0.05 compared with control; + P < 0.05 compared with group 240 (= 240 min of ventilation), 
− = Lower detection limit; 30, 60, 120, 240 = minutes of ventilation in healthy mice; C = control group 
(unventilated, healthy mice); D = leukocyte-depleted group (these animals were leukocyte depleted 
before 240 min of mechanical ventilation and were killed immediately thereafter); R = recovery group 
(these animals were ventilated for 240 min and analyzed after 2 days recovery).
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In plasma, TNF-a, IL-6 and KC levels were elevated from 120 min onward compared with 
group C animals, and IL-1a after 240 min of MV. IL-1b and IL-10 levels were not different from 
those of the group C animals (fig. 4).
When animals were allowed to recover for 2 days (group R), after being ventilated for 240 
min, all lung tissue cytokine levels were lower compared with levels found in animals killed 
Figure 4: Cytokine levels in plasma.
Mechanical ventilation significantly increases tumor necrosis factor (TNF)-a, interleukin (IL)-6 and 
keratinocyte-derived chemokine (KC) plasma levels from 120 min onward compared with unventilated 
animals (group C); IL-1a level was increased only after 240 min. When animals were allowed to recover for 
2 days (group R) TNF-a, IL-6, IL-10, and KC were found to be lower when compared with levels found in 
animals killed immediately after 240 min of ventilation (group 240). In leukocyte-depleted animals (group 
D), mechanical ventilation resulted in significantly higher levels of plasma levels for KC compared with 
group C animals. TNF-a, IL-6, and IL-10 plasma levels were lower compared with the levels found after 240 
min of mechanical ventilation in healthy animals (group 240). Data are expressed as box (median, 25th 
and 75th percentiles) and whiskers (range). * P < 0.05 compared with control. + P < 0.05 compared with 
group 240 (= 240 min of ventilation). − = Lower detection limit; 30, 60, 120, 240 = minutes of ventilation in 
healthy mice; C = control group (unventilated, healthy mice); D = leukocyte-depleted group (these animals 
were leukocyte depleted before 240 min of mechanical ventilation and killed immediately thereafter). R = 
recovery group (these animals were ventilated for 240 min and analyzed after 2 days recovery).
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immediately after 240 min of ventilation (group 240). IL-1a and KC levels in group R animals 
were higher compared with group C animals. Plasma levels of TNF-a, IL-6, IL-10 and KC were 
found to be lower when compared with group 240.
The Effect of Leukocyte Depletion on the Release of Cytokines:
In leukocyte-depleted animals (group D), MV resulted in significantly higher levels of lung tis-
sue IL-1a, IL-6, IL-10, and KC compared with group C animals. IL-1b, TNF-a, and KC levels were 
lower compared with the levels found after 240 min of MV in healthy (non-leukocyte depleted) 
animals (group 240). MV resulted in higher plasma levels of KC compared with group C animals. 
TNF-a, IL-6, and IL-10 levels in plasma were lower compared with the levels found in group 240.
No lipopolysaccharide could be detected in our experimental setting.
dIsCussIon
The current study demonstrates that MV in healthy mice using clinically relevant ventilator 
settings with low VT preserves alveolar integrity but induces reversible cytokine increase and 
leukocyte influx. This rapid increase in cytokine levels and leukocyte influx, however, does not 
result in persistent inflammation and VILI.
Our findings suggest that “noninjurious” or “lung-protective” ventilation does not exist and 
that even this careful mode of ventilation strategy leads to a reversible inflammatory response. 
Fortunately, MV in elective, healthy patients rarely leads to clinical significant injury. Apparently, 
in most circumstances the lung is able to cope with the MV-induced inflammatory reaction. This 
is demonstrated in a clinical study by Plotz et al.36 which showed that 2 h of MV (VT of 10 ml/
kg) in healthy children, anesthetized for cardiac catheterization, resulted in elevated alveolar 
IL-6 and TNF-a concentrations without clinical signs of pulmonary dysfunction. In contrast with 
this are the findings in the clinical study of Wrigge et al.37 who found no ventilation-induced 
increase in cytokines. However, in this study the ventilation duration was limited to one hour 
and cytokines were only measured in plasma and not in the lung.
The current study is essentially different from previous experimental studies. In those stud-
ies either injurious MV settings with large tidal volumes and high peak inspiratory pressures 
were used,11;12;14;26;27;38 or lungs were preinjured using lipopolysaccharide, hydrochloric acid or 
surfactant depletion.13;15;16;28;29 Another major difference is that cytokine levels were measured 
in lung lavage fluid, whereas we used lung tissue homogenate.11;12;14;38 Lung lavage - by itself 
potentially injurious as it is often performed using large volumes11;12;38 requires cellular and 
alveolar leakage for the detection of cytokines. Analysis of lung tissue homogenate allows 
detection of cytokines before appearance in the alveolar space. This method of material 
harvesting does not allow the identification of the specific cells responsible for the measured 
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increases in cytokine levels. However, the observed increase in KC after 30 min of MV, before the 
leukocyte influx, suggests a primary pulmonary origin of this cytokine. This is further supported 
by the finding of KC elevation in the leukocyte-depleted animals (group D). However, we did 
not study the possible effects of cyclophosphamide on cytokine synthesis of pulmonary cells.
In this study, EM analysis revealed that our MV mode almost completely retained histologic 
integrity, with only sporadically minimal changes in a few samples. Most importantly, base-
ment membranes were not disrupted, signifying alveolar integrity. Although LM has been used 
for quantitative analysis of leukocytes and can provide some qualitative evidence of lung injury 
(i.e., alveolar flooding, thickening of alveolar septa),39;40 more detailed evaluation of structural 
changes in the lung requires EM.41 The effects of large VT in the animals ventilated with VT of 16 
ml/kg was clearly visible with EM as damage with loss of compartmentalization, consistent with 
findings in a previous publication.9 We observed increased wet/dry ratios in animals after 240 
min of MV. However, we conclude that this increased wet/dry ratio (without any other signs of 
possible lung damage as shown by EM and LM examination) is not of clinical significance. This is 
supported by the finding of the complete recovery of the animals who were allowed to recover 
after 240 min of ventilation (group R).
Factors affecting cytokine response other than MV were carefully avoided. The possibility of 
triggering an inflammatory response by invasive procedures (i.e., insertion of an intraarterial 
line),18 was eliminated by performing our experiments in non-invasively monitored animals, 
after having documented cardiorespiratory stability in invasively monitored animals (IABP-
group). A limulus amebocyte lysate test excluded possible aerogenic lipopolysaccharide 
contamination during our experiments. Cardiorespiratory parameters and the choice of the 
anesthetics are known to influence the cytokine profile. In the current study mean arterial pres-
sure was maintained above 65 mmHg and blood gas analysis showed normal pH, PaCO2 and 
PaO2 levels. Only a small decrease in base excess after 120 and 240 min of MV was observed, 
comparable with other studies.11;12 The slight decrease in base excess in the presence of a nor-
mal mean arterial pressure unlikely interferes with our observations. The effect of anesthetics 
on hemodynamic stability in mice has been studied extensively by Zuurbier et al.42 who found 
KMA mix superior compared with other regimes (e.g., fentanyl – fluanisone – midazolam mix 
or isoflurane). Some anesthetics, e.g., propofol,43 volatile anesthetics,44;45 and ketamine,46;47 are 
known to influence cytokine profiles. Ketamine is known to have an inhibitory effect on lipo-
polysaccharide-induced cytokine production.46;48-50 In the current study all animals received 
the KMA mix. Ideally, an additional control group of spontaneously breathing animals under 
KMA-anesthesia is needed. However, this will result in hypoventilation with severe respiratory 
acidosis and hemodynamic instability. Two mice in group R (recovery group) died immediately 
following extubation; the cause of death was due to airway problems related to residual effects 
of the anesthesia. The other mice in group R made uneventful recoveries. By excluding these 
confounding factors, we attribute the increase in cytokine levels to MV.
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Therefore, even low-VT MV induces an inflammatory response and, in a “multiple-hit” situa-
tion, might be the additional “proinflammatory” hit resulting in lung injury. Modulation of the 
inflammatory response may offer strategies to reduce VILI. In this respect anesthetics may play 
a role because volatile anesthetics have been shown to exhibit antiinflammatory effects in dif-
ferent organ systems and might be able to modulate the release of cytokines.51 The influence 
of different anesthetics on the inflammatory response in our model needs further investigation. 
Recently Jiang et al.52 discovered that Toll-like receptor-4 mediated inflammation by endog-
enous compounds might also be important in the development of VILI. Further study of the 
Toll-like receptors and the molecules with which they interact may reveal more insight into the 
molecular mechanisms of VILI.
ConCLusIon
The current study shows that in healthy male mice, a short period of “noninjurious” ventilation 
induces a reversible inflammatory reaction, while preserving tissue integrity. This model offers 
opportunities to study the pathophysiological mechanisms of VILI and the contribution of MV 
to the “multiple-hit” concept.
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Low tidal volume mechanical ventilation induces 
a toll-like receptor 4 dependent inflammatory 
response in healthy mice.
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abstraCt
Background:
 Mechanical ventilation (MV) can induce ventilator-induced lung injury. A role for pro-inflamma-
tory pathways has been proposed. The present studies analyzed the roles of Toll-like receptor 
(TLR)-4 and TLR2 involvement in the inflammatory response following MV in the healthy lung.
Methods:
Wild type (WT) C57BL6, TLR4 knock out (KO) and TLR2 KO mice were mechanically ventilated 
for 4 hours. Broncho-alveolar lavage fluid was analyzed for presence of endogenous ligands. 
Lung homogenates were used to investigate changes in TLR4 and TLR2 expression. Cytokines 
were measured in lung homogenate and plasma and leucocytes were counted in lung tissue.
Results:
MV significantly increased endogenous ligands for TLR4 in broncho-alveolar lavage fluid and 
relative mRNA expression of TLR4 and TLR2 in lung tissue. In lung homogenates, MV in WT mice 
increased levels of keratinocyte-derived chemokine (KC), interleukin (IL)-1a and IL-1b. In TLR4 KO 
mice MV increased IL-1a, but not IL-1b and the increase in KC was less pronounced. In plasma, MV 
in WT mice increased levels of IL-6, KC and tumor necrosis factor-a. In TLR4 KO mice MV did not 
increase levels of IL-6 and tumor necrosis factor-a and the response of KC was less pronounced. 
MV in TLR2 KO mice did not result in different cytokine levels compared with WT mice. In WT and 
TLR2 KO, but not in TLR4 KO mice, MV increased the number of pulmonary leukocytes.
Conclusions:
The current study supports a role for TLR4 in the inflammatory reaction following short-term 
MV in healthy lungs. Increasing the understanding of the innate immune response to MV may 
lead to future treatment advances in ventilator-induced lung injury, in which TLR4 may serve 
as a therapeutic target.
TLR4 involvement in ventilator induced lung injury
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IntroduCtIon
Mechanical ventilation (MV) facilitates surgical interventions under general anesthesia and is a 
life saving intervention in acute respiratory failure. However, MV can induce lung injury; this has 
been termed ventilator-induced lung injury (VILI).1 VILI can exacerbate damage in the already 
injured lung but can also occur in healthy lung.2 The mechanisms of VILI are incompletely 
understood but a role for pro-inflammatory pathways has been proposed.3
Animal models have been used to study the pathophysiology underlying VILI. Traditionally, 
in these models lungs were preinjured, for instance by lipopolysaccharide.4 Lipopolysaccharide 
is a component of the outer membrane of Gram-negative bacteria. Upon binding to Toll-like 
receptor (TLR)-4,5 lipopolysaccharide induces an intense inflammatory response leading to 
lung injury.6-8 TLRs are essential in host defense against pathogens by virtue of their capacity to 
recognize various microbes and initiate an immune response.9
To date, 12 TLRs have been identified in mammals.5 Recent studies indicate that TLRs not 
only recognize microbial products, but also endogenous ligands released from damaged tis-
sue, the so-called ‘danger signals’.10;11 Non-infectious lung injury induced by hemorrhage,12-14 
ischemia-reperfusion,15 contusion,16 hyperoxia or administration of bleomycin,17 resulted in 
inflammatory reactions via TLR4 and/or TLR2 signaling supporting the existence of endog-
enous ligands. Recently, endogenous ligands for TLR4 and TLR2 were identified, including heat 
shock protein 60,18 fibronectin,19 heparan sulfate proteoglycan,20 biglycan,21 hyaluronan22 and 
the myeloid-related proteins 8 and 14.23
The concept of TLR mediated inflammation by endogenous ligands is interesting and may 
be involved in the development of VILI in the normal lung. Recently, we have shown that low 
tidal volume MV in healthy mice induces a transient inflammatory response without altering 
the structural integrity of the lung.24 The aim of the present study was to test the hypothesis 
that TLR4 and/or TLR2 receptor signaling is involved in the inflammatory response induced by 
MV in the healthy lung. To test this hypothesis wild type (WT), TLR4 knock out (KO) and TLR2 KO 
mice were mechanically ventilated.
MaterIaL and MetHods
All experiments were approved by the Regional Animal Ethics Committee in Nijmegen and per-
formed under the guidelines of the Dutch Council for Animal Care and the National Institutes of 
Health. The current study protocol was designed after a pilot study was performed.
Animals:
All experiments were carried out in adult male C57BL6 mice (n=64): TLR4 KO (C57BL6 back-
ground) mice (10-12 wk) (n=14; body weight 30 (±3) gram) and age matched wild type (WT) 
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mice (n=40; body weight 25 (±3) gram). In a separate set of experiment TLR2 KO (C57BL6 
background) mice (22-24 wk) (n=5; body weight 30 (±2) gram) and age matched WT mice (n=5; 
body weight 33 (±2) gram) were used. All KO mice were extensively backcrossed (at least 10 
times) and were a kind gift from professor Shizuo Akira M.D., Ph.D., Osaka University, Osaka, 
Japan. WT mice were purchased from Charles River, Sulzfeld, Germany.
Mechanical ventilation in mice:
Mice were anesthetized with an intraperitoneal injection of a combination of ketamine, 
medetomidine and atropine as described previously.24 Mice in the unventilated groups were 
sacrificed immediately after induction of anesthesia. Mechanically ventilated (MiniVent®, Hugo 
Sachs Elektronik-Harvard apparatus, March-Hugstetten, Germany) animals were orally intu-
bated, ventilated for 4 hours and sacrificed immediately thereafter. The following settings were 
used during controlled MV: tidal volume 8 ml/kg body weight, frequency 150/min, positive 
end-expiratory pressure 4 cm H2O and fraction of inspired oxygen 0.4. Rectal temperature was 
monitored continuously and maintained between 36.0ºC and 37.5ºC using a heating pad.
Experimental design:
The first set of experiments was performed to investigate the presence of endogenous ligands 
for TLR4 in broncho-alveolar lavage (BAL) fluid. BAL was performed after 4 hours of MV (group 
V-WT, n=8) or directly after induction of anesthesia (group C-WT, n=8).
The second set of experiments was designed to investigate changes in pulmonary TLR4 
and TLR2 expression in WT mice and to investigate changes in cytokine profile in wild type 
and TLR4 KO mice following MV. Blood and lungs were harvested after 4 hours of MV in WT 
(group VTLR4WT, n = 8) and TLR4 KO mice (group VTLR4KO, n = 8) or immediately after induction 
of anesthesia in WT (group CTLR4WT, n = 8) and TLR4 KO mice (CTLR4KO, n = 6).
In the third set of experiments the role of TLR2 in MV-induced inflammation was studied. 
Blood and lungs were harvested after 4 hours of MV in WT (group VTLR2WT, n=5) and TLR2 KO 
mice (group VTLR2KO, n=5).
Lipopolysaccharide was measured in air, tubing, ventilator and BAL fluid from unventilated 
animals (n=4) by Limulus Amebocyte Lysate testing (Cambrex Bio Science, Walkersville, USA; 
detection limit: 0.06 IU/ml) to rule out contamination with lipopolysaccharide in our experi-
mental setting.
Tissue harvesting:
Blood was collected by exsanguination, centrifuged at 14,000 rpm / (13,000 g) (Eppendorf 5415 
C, Nethler-Hinz GmbH, Hamburg) for 2 minutes and plasma was stored at -80°C. Immediately 
after exsanguination, heart and lungs were carefully removed en block via midline sternotomy. 
The right upper and lower lobe were snap frozen in liquid nitrogen and stored at -80ºC. The 
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right middle lobe was fixed for light microscopy (LM). The left lung was homogenized for mea-
surement of cytokine concentrations.
Broncho-alveolar lavage and analysis for the presence of endogenous ligands:
For the BAL procedure 250 ml of sterile saline (0.9%) of 37ºC was injected and gently aspirated 
through the endotracheal tube. Lavage fluid was snap frozen in liquid nitrogen and stored at 
-80ºC. Human embryonal kidney (HEK)-293-TLR4 cell lines were purchased from InvivoGen 
(San Diego, California, USA) and cultured according to the manufacturer’s guidelines. For 
stimulation, 5.104 cells/well were used in flat-bottom 96-wells plates. HEK293-TLR4 cells were 
exposed to 50mL of BAL fluid and added to 200 mL culture medium for 24 hours. Subsequently, 
interleukin (IL)-8 was measured in culture supernatants using Luminex bead array technol-
ogy. To verify the presence of endogenous TLR4 ligands, the BAL fluid was incubated with or 
without 10 mg/ml B. quintana lipopolysaccharide as a specific TLR4 antagonist.25;26 To rule out 
lipopolysaccharide contamination, we performed the HEK-293-TLR4 assay in the presence and 
absence of polymyxin B (2 mg/mL) with BAL fluid from ventilated WT mice (n=4).
mRNA analysis of lung homogenates:
For Polymerase Chain Reaction (PCR) analysis of mRNA, the right upper and lower lobe were 
homogenized with a micro-dismembrator II (Braun, Melsungen, Germany). Total RNA was 
extracted in 1 ml TRIzol reagent. Subsequently 200 µL chloroform and 500 µl 2-propanol (Merck, 
Darmstadt, Germany) were used to separate the RNA from DNA and proteins. After a wash step 
with 75% ethanol (Merck, Darmstadt, Germany) the dry RNA was dissolved in 30 µL of water.
To obtain double strain cDNA, DNase treated total RNA 1 mg with oligo dT primers (0.01 µg/ml) 
was reverse transcribed in a RT-PCR with a total volume of 20 µl. Subsequently, quantitative PCR 
was performed using ABI/PRISM 7000 Sequence Detection System (Applied Biosystems, Foster 
City, CA). PCR’s of glyceraldehyde-3-phosphate dehydrogenase, TLR2 and TLR4 were performed 
with Sybr Green PCR Master Mix (Applied Biosystems, Foster City, CA), 5 µL 1/20 diluted cDNA 
and primers in a final concentration of 300 nmol/L in a total volume of 25 µL. The primers were 
developed using Primer Express® software (Applied Biosystems, Foster City, CA). Quantification 
of the PCR signals of each sample was performed by comparing the cycle threshold values 
(Ct), in duplicate, of the gene of interest with the Ct values of the glyceraldehyde-3-phosphate 
dehydrogenase housekeeping gene. TLR2 and TLR4 mRNA expression was expressed as relative 
expression to the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase. All primers 
were validated according to the protocol and standard curves were all within the tolerable range.
Cytokine analysis in lung homogenates and plasma:
Tumor necrosis factor (TNF)-a, IL-6, IL-10, and Keratinocyte-derived chemokine (KC) in the 
homogenized left lung and in plasma were analyzed by enzyme-linked-immunosorbent assay 
(ELISA) (for TNF-a, IL-6 and IL10; CytoSet, BioSource, USA; for KC; ELISA-Kit, R&D, USA). IL-1a and 
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IL-1b were only assessed in lung homogenates, because of insufficient plasma, using specific 
radio-immuno-assays, as described previously.27 Lower detection limits: IL-1a and IL-1b; 40 pg/
ml, TNF-a; 32 pg/ml, IL-6; 160 pg/ml, IL-10; 16 pg/ml and KC; 160 pg/ml.
Histological examination:
The right middle lung lobe was fixed in 4% buffered formalin solution overnight at room tem-
perature, dehydrated and embedded in paraplast (Amstelstad, Amsterdam, The Netherlands). 
Sections of 4 μm-thickness were used. The enzyme activity of leukocytes was visualized by 
enzyme histochemistry using chloracetatesterase staining (Leder staining). Leukocytes were 
counted manually (20 fields per mouse), and after automated correction for air/tissue ratio, the 
number of leukocytes/μm2 was calculated.
Statistical Analysis:
Data are expressed as mean (SD) when distributed normally (body weight, endogenous ligands, 
relative mRNA expression, leukocyte counts) and expressed as median (range) otherwise 
(cytokine concentrations). Statistical analysis was performed with SAS (SAS Institute Inc. Cary 
NC, USA) statistical procedures. Since cytokine concentrations are not normally distributed, 
Kruskal Wallis procedures were used, with post hoc comparisons of subgroups (Duncan). Data 
of a particular cytokine concentration variable were ranked, followed by ANOVA in the General 
Linear Models procedure using the MEANS procedure with the Duncan option and Bonferroni 
correction for multiple comparisons. For analysis of endogenous ligands, relative mRNA expres-
sion and leukocyte counts ANOVA was used on non-ranked data with post hoc comparison of 
group means. The level of significance was set at P < 0.05.
resuLts
Presence of endogenous ligands for TLR4 and TLR4/TLR2 mRNA expression after mechanical ventilation:
BAL fluid from unventilated WT mice resulted in increased production of IL-8 by HEK293-TLR4 
cells compared with the medium. This could only be partly reduced by co-incubation with a 
highly specific TLR4 antagonist, indicating that these cells generate IL-8 in a TLR4 independent 
manner as well (see discussion, role for endogenous ligands). BAL fluid from ventilated WT 
mice induced a significantly higher IL-8 response compared with BAL from unventilated WT 
mice and co-incubation with a highly specific TLR4 antagonist did significantly reduce the IL-8 
response (figure 1). From the experiments performed in the presence of TLR-4 antagonist, it can 
be derived that the TLR4 dependent response was approximately 5 fold higher in ventilated WT 
mice compared with unventilated WT mice.
MV increased the relative mRNA expression of TLR4 and TLR2 in lung tissue of ventilated WT 
mice as compared with unventilated WT mice (figure 2).
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Figure 1: Presence of endogenous ligands for Toll-like receptor-4 (TLR4) in broncho-alveolar lavage fluid 
after 4 hours of mechanical ventilation. 
Interleukin-8 production by human embryonal kidney-293-TLR4 reporter cells after exposure to broncho-
alveolar lavage fluid. After 4 hours of mechanical ventilation endogenous ligands for TLR4 were enhanced 
in broncho-alveolar lavage fluid of the ventilated wild type mice (group V-WT) (P < 0.0001) compared with 
unventilated wild type mice (group C-WT). Addition of a highly specific TLR4 antagonist decreased the 
IL-8 production to the level found in unventilated wild type mice (group C-WT). Data expressed as mean 
(SD). * = P < 0.05 compared with group C-WT. 
Figure 2: Pulmonary relative mRNA expression of Toll-like receptor (TLR) 4 and TLR2 after 4 hours of 
mechanical ventialtion.
Mechanical ventilation resulted in enhanced relative mRNA expression of TLR4 (P = 0.008) and TLR2 
(P = 0.0006) in lung tissue of wild type mice (group VTLR4WT) compared with unventilated wild type 
mice (group CTLR4WT). Data are expressed as Box (median, 25th, 75 percentile) and Whiskers (range). 
* = P < 0.05 compared with group C-WT.
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Changes in cytokine concentration induced by MV:
LUNG HOMOGENATES: MV in WT mice increased levels of IL-1a, IL-1b and KC in lung homog-
enates (figure 3). However, in TLR4 KO mice MV did not increase IL-1b in lung homogenates and 
the MV-induced increase in KC was less pronounced. Interestingly, TLR4 KO did not reduce the 
response of IL-1a to MV. Neither MV, nor TLR4 KO did affect TNF-a, IL-6 and IL-10 concentrations 
in lung homogenates.
Figure 3. Cytokine levels in lung homogenate
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Figure 3: Cytokine levels in lung homogenates.
Levels of interleukin (IL)-6, keratinocyte-derived chemokine (KC), IL-10, IL-1a, IL-1β and tumor necrosis 
factor-a in unventilated (C) and ventilated (V) wild type (WT) and Toll-like receptor (TLR) 4 knock out 
(KO) mice. Mechanical Ventilation in WT mice (group VTLR4WT) increased KC (P < 0.0001), IL-1a (P = 0.003) 
and IL-1b (P < 0.0001) in lung tissue homogenates when compared with unventilated WT mice (group 
CTLR4WT). In TLR4 KO mice (VTLR4KO) mechanical ventilation did not increase IL-1b in lung homogenates. 
Mechanical ventilation in TLR4 KO (VTLR4KO) mice did increase levels of KC (P = 0.0003) and IL-1a (P = 
0.003) when compared with unventilated TLR4 KO mice (group CTLR4KO). Ventilated TLR4 KO mice (group 
VTLR4KO) showed significantly lower levels of KC (P < 0.0001) and IL-1b (P = 0.0005) in lung homogenates 
compared with ventilated WT mice (group VTLR4WT). Between unventilated animals the levels of KC (P = 
0.0069) and IL-1b (P= 0.048) in lung homogenates where higher in the TLR4 KO mice (CTLR4KO) compared 
with WT mice (CTLR4WT). Data are expressed as Box (median, 25th, 75 percentile) and Whiskers (range). 
* = P < 0.05 compared with age matched unventilated mice. + = P < 0.05 compared with ventilated WT 
mice (VTLR4WT). # = compared with unventilated WT mice (CTLR4WT). - = lower detection limit.
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PLASMA: In WT mice, MV was associated with significantly increased levels of IL-6, KC and 
TNF-a in plasma (figure 4). In TLR4 KO mice MV did not increase plasma levels of IL-6 and TNF-a. 
MV did result in increased levels of KC, although the response was less pronounced than in WT 
mice (figure 4).
Figure 4. Cytokine levels in plasma
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Figure 4: Cytokine levels in plasma.
Levels of interleukin (IL)-6, keratinocyte-derived chemokine (KC), IL-10 and tumor necrosis factor-a in 
unventilated (C) and ventilated (V) wild type (WT) and Toll-like receptor (TLR) 4 knock out (KO) mice. 
Mechanical ventilation in WT mice (group VTLR4WT) increased IL-6 (P < 0.0001), KC (p < 0.0001) and tumor 
necrosis factor-a (P = 0.04) in plasma when compared with unventilated WT mice (group CTLR4WT). In 
TLR4 KO mice (VTLR4KO) MV did increase KC (P < 0.0001) in plasma when compared with unventilated TLR4 
KO mice (group CTLR4KO); however, this response was significantly lower (P = 0.0002) compared with the 
ventilated WT mice (group VTLR4WT). No differences were found in the plasma levels of cytokines in the 
unventilated groups. The median of TNF alpha in the V-WT group is not visible because this coincided 
with the 25 percentile. Data are expressed as Box (median, 25th, 75 percentile) and Whiskers (range). 
* = P < 0.05 compared with their own unventilated mice. + = P < 0.05 compared with ventilated WT mice 
(VTLR4WT). - = lower detection limit.
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MV in TLR2 KO mice did not result in statistically different cytokine levels in lung tissue homog-
enates and plasma compared with their age matched WT ventilated animals (figure 5 and 6).
Histological examination:
In WT mice, MV increased the number of pulmonary leukocytes (table 1). In TLR4 KO mice MV 
did not affect the number of leukocytes in the lung. Unventilated TLR4 KO mice expressed a 
higher number of pulmonary leukocytes when compared with unventilated WT mice.
The number of pulmonary leukocytes in ventilated TLR2 KO mice were not different from 
those in the age matched ventilated WT mice ( table 1).
No lipopolysaccharide contamination was detected in our experimental setting and BAL fluid 
from unventilated mice .
Figure 5. Cytokine levels in lung homogenate
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Figure 5: Cytokine levels in lung homogenates.
Levels of interleukin (IL)-6, keratinocyte-derived chemokine (KC), IL-10, IL-1a, IL-1β and tumor necrosis 
factor-a in ventilated (V) wild type (WT) and Toll-like receptor (TLR) 2 knock out (KO) mice. Mechanical 
ventilation in TLR2 KO mice did not result in statistically different cytokine levels in lung tissue 
homogenates compared with their age matched WT ventilated animals.
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Figure 6. Cytokine levels in plasma
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Figure 6: Cytokine levels in plasma.
Levels of interleukin (IL)-6, keratinocyte-derived chemokine (KC), IL-10 and tumor necrosis factor-a in 
ventilated (V) wild type (WT) and Toll-like receptor (TLR) 2 knock out (KO) mice. Mechanical ventilation 
in TLR2 KO mice did not result in statistically different cytokine levels in plasma compared with their age 
matched WT ventilated animals.
Table 1. Leukocyte counts. 
Groups Leukocytes x 10-4 / μm2
Mean (SD)
Delta
due to MV
 P value
CTLR4WT 1.9 (2.6)
VTLR4WT 8.7 (5.1) 6.8 P < 0.001
CTLR4KO 7.2 (5.1) P < 0.001
VTLR4KO 6.1 (4.1) -1.1 NS
VTLR2WT 3.0 (2.1) NS
VTLR2KO 4.0 (3.2) 1.0 NS
Values are mean (SD)
MV = mechanical ventilation
NS = not significant
Toll-like receptor (TLR) 4: P -values compared to the unventilated WT animals (group CTLR4WT). TLR2: P 
-values compared to the ventilated WT animals (group VTLR2WT).
C = unventilated; KO = knock out; MV = mechanical ventilation; NS = not significant; V = ventilated; WT = 
wild-type
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dIsCussIon
This study is the first to reveal several key findings regarding the role of TLR4 signaling in the 
development of MV-induced inflammation in healthy mice. Within the time-frame studied, we 
found that low tidal volume MV resulted in elevated expression of endogenous TLR4 ligands 
in BAL and enhanced mRNA levels for TLR4 in lung homogenates. In addition, short-term MV 
resulted in the increase of inflammatory cytokines in the lung and in a systemic inflammatory 
response in plasma. MV-induced inflammation appeared at least partially TLR4 dependent.
Mechanical ventilation-induced inflammatory response:
The present study confirms previous findings regarding changes in cytokine profile, induced by 
MV, in lungs and plasma of healthy mice.24 Little has been published about the effects of low 
tidal volume MV on cytokines in lungs and plasma of healthy animals. In accord with our results 
are an increase of IL-1b mRNA expression in lung tissue,28 an increase of TNF-a concentration 
in plasma 29 and the lack of response of IL-6 and TNF-a in lung homogenates,30;31 following 
low tidal volume MV. The finding of an increased response of IL-6 in plasma but not in lung 
homogenate can be a time-dependent effect as shown in a previous study.24 IL-6 levels peaked 
in lung homogenates after two hours of MV and decreased thereafter. However, in plasma the 
highest value was reached after 4 hours. In contrast to our results Dhanireddy et al.30 found no 
increase of KC in lung homogenate and plasma following low tidal volume MV and Takenaka 
et al.32 did not find an increase of IL-6 and TNF-a in plasma following low tidal volume MV. 
These different results might be partly explained by differences in ventilator settings and 
experimental set-up in these studies. The present study demonstrates that TLR4 plays a role in 
development of the inflammatory response following MV in healthy lungs. MV in TLR4 KO did 
not increase IL-1b in lung homogenates and increases of KC in lung homogenates were less 
pronounced compared with WT mice. KC and IL-1b are found to play an early and central role 
in lung injury induced by hemorrhage.14;33 IL-1b also is involved in lung injury induced by liver 
injury.34 Recently IL-1a rather than IL-1b was identified as a key mediator in sterile inflammation 
in response to injured cells.35 Our results demonstrate that both IL-1a and IL-1b are involved in 
the inflammatory response following MV, but only the increase in IL-1b was found to be TLR4 
dependent. KC is a chemoattractant, but also has a direct cytotoxic effect.36 Jiang et al.17 found 
KC to be produced by pulmonary epithelial cells in a TLR dependent manner, however this 
was in direct response to bleomycin. More recently, functional TLR4 expression was found to 
be critical in the KC increase following hemorrhage.14 Our results show that KC production in 
response to MV in healthy lungs appears to be at least partly TLR4 dependent.
The clinical relevance of the cytokine up-regulation by MV is the resulting pro-inflammatory 
state. This makes the host more vulnerable to a possible “second hit” (e.g., major surgery).37 
Vice versa, MV itself can be the ”second hit” where an already comprised host exists (e.g., MV in 
the critically ill patient).38-40 Recently this “two hit” hypothesis was linked to TLR4 reactivity.41 
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Inhibition of TLR4 may be an effective strategy to prevent or reduce MV-induced pulmonary 
and systemic inflammation.
Role for leukocytes:
The activation and attraction of leukocytes is a very important feature in VILI.42 Leukocytes 
are thought to be a principal culprit in sterile inflammation causing tissue damage.35 KC is a 
major attractant for leukocytes.43 In a previous study,24 we have shown that 4 hours of MV in 
healthy mice preserves alveolar integrity but induces a pulmonary leukocyte influx following 
the increase of KC in the lung. In the present study this pulmonary leukocyte influx is confirmed, 
however in TLR4 KO mice MV did not affect the number of pulmonary leukocytes. Recently 
Frink et al.14 published a hemorrhage model in which the pulmonary leukocyte influx following 
hemorrhage was also found to be TLR4 dependent.
In the present study the number of pulmonary leucocytes was significantly higher in 
unventilated TLR4 KO mice compared with unventilated WT mice. TLR4 KO mice also showed 
increased lung homogenate levels of KC and IL-1b compared with WT mice at baseline. Frink 
et al.14 did not find differences in leukocyte content before hemorrhage, however in that study 
TLR4 mutant mice were used, which have a different background (C3H/HeJ). Since in these 
mice the defect is not complete, partial responses of TLR4 could be preserved. In the present 
study TLR4 KO mice were used. The absence of TLR4 increases their sensitivity to infections.44 
However prior to the experiments these mice did not exhibit clinical signs of discomfort or 
chronic infection (i.e. abnormal behavior, weight loss). The higher number of pulmonary leuko-
cytes in unventilated TLR4 KO mice is most likely the result of the increased lung homogenate 
levels of KC.
Role for endogenous ligands:
Recently, a number of studies suggested that endogenous ligands exists that can bind to 
TLR4 and induce an inflammatory response.18-23;45 By using HEK293-TLR4 reporter cells, which 
produce IL-8 in the presence of TLR4 agonists, we sought for endogenous TLR4 ligands in BAL 
fluid sampled from unventilated and ventilated WT mice. The IL-8 response in BAL fluid from 
ventilated mice was remarkably enhanced compared with unventilated mice and the addition 
of a highly specific TLR4 antagonist decreased the induction of IL-8, indicating the presence of 
endogenous TLR4 ligands in ventilated mice BAL fluid. HEK293-TLR4 cells incubated with BAL 
fluid from unventilated mice also induced a IL-8 response. This interesting observation could 
suggest that endogenous ligands for TLR4 are present in the normal (unventilated) lung and 
released in the air spaces. This might be explained by direct lung injury, induced by performing 
the BAL procedure as lung lavage is potentially injurious, especially when large volumes are 
used.46 We used small volumes for our BAL procedure, but nevertheless cannot exclude that this 
induces some degree of lung injury and subsequent release of endogenous ligands. The fact 
that the IL-8 response could only partly be prevented by co-incubation with a TLR4 antagonist 
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suggests that other non-TLR4 mediated factors play a role. We found that the HEK293-TLR4 
cells can also respond to recombinant mouse TNF-a in vitro (personal communication Joosten 
L.A. and Netea M.G., august 2007). Since small concentrations of TNF-a can be present in BAL 
fluid of healthy mice,47 this most likely caused the IL-8 response in the unventilated mice. Most 
importantly, the IL-8 response was much higher in BAL fluid from ventilated WT mice compared 
with unventilated WT mice and co-incubation with a TLR4 antagonist prevented this response. 
This indicates elevated concentrations of endogenous TLR4 ligands following MV.
In a non-infectious lung injury model, Jiang et al.17 found hyaluronan, which is released from 
the extracellular matrix, to act as an endogenous ligand and initiate an inflammatory response 
in a TLR4 dependent manner. Hillman et al.48 showed that heat shock protein-70, serum amyloid 
A-3 and TLR2 and TLR4 mRNA were increased in BAL fluid after brief, large tidal volume ventila-
tion in fetal sheep. Since the identification of specific endogenous ligands for TLR4 in healthy 
lungs after MV was beyond the scope of the present study, further investigation is needed.
The present data suggest that TLR2 does not play a role in the MV induced inflammatory 
response following short-term MV. Although the relative expression of TLR2 in wild type mice 
was upregulated, the ventilated TLR2 KO mice did not show differences in cytokine levels 
compared with age matched ventilated wild type mice after 4 hours of MV. This is in line with 
preliminary findings in TRIF-deficient mice in which the inflammatory response to MV was 
clearly suppressed (manuscript in preparation). Since TLR2 signaling is MyD88 dependent and 
TLR4 is MyD88 or TRIF dependent,49 it is likely that TLR4-TRIF pathway is the dominant pathway 
for the inflammatory response to MV. However further studies are needed to establish the role 
of TLR2 in MV induced inflammation, because we cannot exclude that TLR2 plays a role in the 
inflammatory response beyond 4 hours of MV.
Factors other than MV, possibly affecting TLR4 and TLR2 signaling were carefully avoided. 
Contamination with lipopolysaccharide is suggested to be a confounding factor in many 
studies.50 We therefore excluded lipopolysaccharide contamination during the experiments. 
The possibility of triggering an inflammatory response by invasive procedures (i.e. insertion 
of an intraarterial line) and subsequent bacterial contamination,37 was eliminated by perform-
ing experiments in non-invasively monitored animals. Previously cardiorespiratory stability 
in invasively monitored animals has been documented.24 The possible immune modulating 
effects of anesthetics have been studied extensively.51 Ketamine, for instance, is known to have 
an inhibitory effect on lipopolysaccharide-induced cytokine production,52-55 possibly by sup-
pressing TLR4 expression.56 Recently, it has been demonstrated that ketamine alone (without 
lipopolysaccharide) also attenuated cytokine production in humans in the direct postoperative 
period after elective abdominal surgery.57 In the present study all animals received ketamine. 
Ideally, an additional control group of spontaneously breathing animals under ketamine, 
medetomidine and atropine anesthesia is needed. However, this will result in hypoventilation 
with severe respiratory acidosis and hemodynamic instability.
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Interestingly, a Phase III trial is conducted to investigate the effects of TLR4 inhibition in patients 
with severe sepsis.1 The current study supports a role for TLR4 in the inflammatory reaction 
following MV in healthy lungs. Increasing the understanding of the innate immune response 
to MV and the contribution of MV to the “multiple hit” concept may lead to future treatment 
advances in VILI, in which TLR4 may serve as a therapeutic target.
1 http://www.clinicaltrials.gov last accessed: May 26th, 2008
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interleukin-1 receptor domain-containing 
adapter inducing interferon-beta dependent 
inflammatory response in healthy mice.
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abstraCt
Background:
Mechanical ventilation (MV) can induce lung injury. Pro-inflammatory cytokines have been 
shown to play an important role in the development of ventilator-induced lung injury. Previ-
ously, the authors have shown a role for toll like receptor 4 signaling. The present study aims 
to investigate the role of Toll/interleukin-1 receptor domain-containing adapter inducing 
interferon-b (TRIF), a protein downstream of toll like receptors, in the development of the 
inflammatory response following MV in healthy mice.
Methods:
Wild type C57BL6, and TRIF mutant mice were mechanically ventilated for 4 hours. Lung tissue 
and plasma was used to investigate changes in cytokine profile, leukocyte influx and nuclear 
factor-κB activity. In addition, experiments were performed to assess the role of TRIF in changes 
in cardiopulmonary physiology following MV.
Results:
MV significantly increased messenger RNA expression of interleukin (IL)-1b in wild type mice, 
but not in TRIF mutant mice. In lung homogenates, MV increased levels of IL-1a, IL-1b and 
keratinocyte-derived chemokine in wild type mice. In contrast, in TRIF mutant mice only a minor 
increase in IL-1b and keratinocyte-derived chemokine was found after MV. NF-kB activity after 
MV was significantly lower in TRIF mutant mice compared with wild type mice. In plasma, MV 
increased levels of IL-6 and keratinocyte-derived chemokine. In TRIF mutant mice, no increase 
of IL-6 was found after MV and the increase in KC appeared less pronounced. TRIF deletion did 
not affect cardiopulmonary physiology following MV.
Conclusions:
The current study supports a prominent role for TRIF in the development of the local and 
systemic inflammatory response following MV.
TRIF involvement in ventilator induced lung injury
61
IntroduCtIon
Mechanical ventilation (MV) is a life saving therapy in patients with acute respiratory failure. 
However, studies have shown that MV can aggravate lung injury and even induce lung injury in 
the healthy lung.1 The underlying mechanisms are incompletely understood but a large body 
of literature indicates that pro-inflammatory cytokines play an important role in the develop-
ment of ventilator-induced lung injury.2
Toll-like receptors (TLR) are increasingly being recognized as key mediators in inflammation 
because of their capacity to detect various microbes and initiate an immune response.3 In addi-
tion, TLRs have been shown to recognize endogenous ligands released from damaged tissue, 
the so-called ‘danger signals’.4 TLR4 is found to play a role in acute lung injury.5 Endogenous 
ligands activate TLR4, resulting in an inflammatory response, which is associated with lung 
injury.5 MV using low tidal volume may limit,6 but does not prevent pulmonary inflammation.7 
Recently, we have shown that in healthy mice, MV with low tidal volume induces a transient 
inflammatory response, partly in a TLR4-dependent fashion.8
Downstream signaling of TLRs is complex. MyD88 is a universal adaptor protein used by 
most TLRs.9;10 In TLR4 a second pathway is involved. This pathway is mediated by Toll/inter-
leukin-1 receptor domain-containing adapter inducing interferon-b, a protein called TRIF.9;10 
Activation of TRIF causes delayed translocation of nuclear factor (NF)-κB into the nucleus, and 
transcription of proinflammatory genes inducing cytokine production.11 This TRIF pathway 
has recently been identified as the key signaling pathway in acid-induced lung injury and in 
hyperoxia-induced lung injury.5;12 For instance, in TRIF deleted animals acid-induced impair-
ment in lung function and development of lung edema was less pronounced.5 Whether TRIF is 
involved in the inflammatory response following MV is currently unknown. This is of interest, as 
MV is more clinically relevant than acid- or hyperoxia-induced lung injury.
Accordingly, the aim of the present study was to determine the role of TRIF in the develop-
ment of the inflammatory response and lung function impairment following MV in healthy 
mice. We hypothesized that MV-induced inflammation involves a TRIF dependent pathway. To 
test this hypothesis wild type and TRIF mutant mice were mechanically ventilated for 4 hours.
MaterIaL and MetHods
All experiments were approved by the Regional Animal Ethics Committee (Nijmegen, The 
Netherlands) and performed under the guidelines of the Dutch Council for Animal Care and 
the National Institutes of Health.
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Animals:
In order to test the role of TRIF in our experimental model, studies were conducted using TRIF 
mutant mice (C57BL6 background; 10-12 weeks; 25 ± 4 g; N=31). Age matched wild type (WT) 
mice (C57BL6 background; 26 ± 3 g; N=31) were used as controls. TRIF mutant mice were a kind 
gift from professor B. Beutler (Department of Immunology, The Scripps Research Institute, La 
Jolla, CA), who identified and cloned the TRIF gene (called Lps2).13 These TRIF mutant mice have 
a distal frameshift error in the Lps2 gene, which has an equivalent gene in humans.13 WT mice 
were purchased from Charles River (Sulzfeld, Germany).
Mechanical ventilation in mice:
Mice were anesthetized with an intraperitoneal injection of a combination of ketamine, medeto-
midine and atropine as described previously.7 Animals were orally intubated, mechanically ven-
tilated (MiniVent®, Hugo Sachs Elektronik-Harvard apparatus, March-Hugstetten, Germany) for 
4 hours and killed immediately thereafter. The following settings were used during controlled 
mechanical ventilation: tidal volume 8 ml/kg body weight and frequency 150 / min, which 
is well within the range of measured tidal volume and respiratory rate during spontaneous 
ventilation in C57BL6 mice.14 All animals received 4 cm H2O positive end-expiratory pressure 
and fraction of inspired oxygen was set to 0.4. Rectal temperature was monitored continuously 
and maintained between 36.0ºC and 37.5ºC using a heating pad.
Experimental design:
The first set of experiments was performed to investigate the role of TRIF in MV-induced changes 
in cytokine profile, leukocyte influx and NF-kB activity. Blood and lungs were harvested after 
4 hours of MV in WT mice (group V-WT, n = 8) and TRIF mutant mice (group V-TRIF, n = 8) or 
immediately after induction of anesthesia in WT (group C-WT, n = 8) and TRIF mutant mice 
(group C-TRIF, n = 8)
The second set of experiments was designed to assess changes in cardiopulmonary physiol-
ogy. Continuous intraarterial carotid blood pressure was measured in mechanically ventilated 
WT mice (group V-WT, n = 15) and TRIF mutant mice (group V-TRIF, n = 15). Arterial blood gas 
analysis (iSTAT, Abbott, Birmingham, United Kingdom) was performed after 4 hours of MV. We 
did not include these animals for the cytokine or histopathologic analysis to avoid possible 
interference with cytokine response resulting from instrumentation (i.e. insertion of arterial 
catheter) and subsequent bacterial contamination. One TRIF mutant mice died during instru-
mentation.
Lipopolysaccharide was measured in experimental circuit by Limulus Amebocyte Lysate 
testing (Cambrex Bio Science, Walkersville, MD; detection limit: 0.06 IU/ml) to rule out con-
tamination with lipopolysaccharide in our experimental setting. Indeed, no lipopolysaccharide 
could be detected in air, tubing or ventilator (data not shown).
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Tissue harvesting:
Blood was collected by exsanguination, centrifuged at 14,000 rpm (13,000 g) (Eppendorf 
5415 C, Nethler-Hinz GmbH, Hamburg, Germany) for 2 min and plasma was stored at -80°C for 
later biochemical analysis. Immediately after exsanguination, heart and lungs were carefully 
removed en block via midline sternotomy. The right upper and lower lobes were snap frozen 
in liquid nitrogen and stored at -80ºC. The right middle lobe was fixed for light microscopy as 
described previously.7 The left lung was homogenized for the measurement of cytokines.
Biochemical analysis:
Tumor necrosis factor-a, Interleukin (IL)-6, IL-10, and keratinocyte-derived chemokine (KC) in 
the homogenized left lung and in plasma were analyzed by enzyme-linked-immunosorbent 
assay (ELISA) (for Tumor necrosis factor-a, IL-6 and IL10; CytoSet, BioSource, CA; for KC; ELISA-
Kit, R&D Systems, MN). Because of insufficient amount of plasma, IL-1a and IL-1b could only be 
assessed in lung homogenate using specific radio-immuno-assays, as described previously.15 
Lower detection limits: IL-1a and IL-1b: 40 pg/ml; Tumor necrosis factor-a: 32 pg/ml; IL-6: 160 
pg/ml; IL-10: 80 pg/ml and KC: 160 pg/ml.
NF-κB’s DNA-binding activity was determined by electrophoretic mobility shift assay. Nuclear 
proteins for electrophoretic mobility shift assay were isolated from liquid nitrogen frozen 
lungs. Lung tissue (20 mg) was homogenized in 5ml ice-cold buffer (HEPES 10mM, 1.5mM 
MgCl2
, 10mM KCl and 0.6% Nonidet-P40, 0.5 mM dithiothreitol and 0.2 mM phenylmethyl-
sulphonylfluoride (Sigma-Aldrich, Zwijndrecht, The Netherlands) and centrifuged for 30s at 
350 g (4°C). The supernatant was then incubated on ice for 5 min and centrifuged for 5 min 
at 6,000 g (4°C). The pellet was resuspended in 200µl buffer (10 mM HEPES, 1.5 mM MgCl2, 10 
mM KCL and 1.2 M sucrose, 0.5 mM dithiothreitol and 0.2 mM phenylmethylsulphonylfluoride 
(Sigma-Aldrich)) and centrifuged for 30 min at 13,000 g (4°C). Then the pellet was resuspended 
in 66 µl buffer (HEPES 20mM, 1.5mM MgCl2, 0.2 mM EDTA, 420 mM NaCl, 25% glycerol, 0.5mM 
dithiothreitol, 0.2mM phenylmethylsulphonylfluoride, 2.0 mM benzamidine and 5.0 µg/ml 
leupeptine (Sigma-Aldrich), incubated on ice for 20 min and centrifuged for 2 min at 6,000 g 
(4°C). The supernatants were used as nuclear extracts. Protein concentrations in these extracts 
were determined by using the Bio-Rad protein assay (Bio-Rad, Veenendaal, The Netherlands).
Double stranded oligonucleotides containing an NF-κB consensus binding site (5’-AGTT-
GAGGGGACTTTCCCAGGC-3’) were radiolabeled with 32[P]-adenosine triphosphate using T4 
polynucleotide kinase (Promega, Madison, WI). Labeled NF-κB oligonucleotides were mixed 
with nuclear extracts (10 µg) and incubated at room temperature for 20 min. Then, these 
samples were loaded on a 4% polyacrylamide gel. After electrophoresis for 45 min, the gel was 
dried and exposed for 24 hours to an X-ray film. The bands on the film were quantified using 
optical densitometry software (GeneTools, Syngene, Cambridge, UK).
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mRNA analysis of lung homogenates:
For Polymerase Chain Reaction (PCR) analysis of mRNA, the right upper and lower lobe were 
homogenized with a micro-dismembrator II (Braun, Melsungen, Germany). Total RNA was 
extracted in 1 ml TRIzol reagent. Subsequently 200 µL chloroform and 500 µl 2-propanol (Merck, 
Darmstadt, Germany) were used to separate the RNA from DNA and proteins. After a wash step 
with 75% ethanol (Merck, Darmstadt, Germany) the dry RNA was dissolved in 30 µL of water. 
To obtain double strain cDNA, DNase treated total RNA 1 µg with oligo dT primers (0.01 µg/ml) 
was reverse transcribed in a RT-PCR with a total volume of 20 µl. Subsequently, quantitative 
PCR was performed using ABI/PRISM 7000 Sequence Detection System (Applied Biosystems, 
Foster City, CA). PCR’s of glyceraldehyde-3-phosphate dehydrogenase, IL-1β were performed 
with Sybr Green PCR Master Mix (Applied Biosystems, Foster City, CA), 5 µL 1/20 diluted cDNA 
and primers in a final concentration of 300 nmol/L in a total volume of 25 µL. The primers were 
developed using Primer Express® software (Applied Biosystems, Foster City, CA). Quantification 
of the PCR signals of each sample was performed by comparing the cycle threshold values 
(Ct), in duplicate, of the gene of interest with the Ct values of the glyceraldehyde-3-phosphate 
dehydrogenase housekeeping gene. IL-1β messenger RNA expression was expressed as 
relative expression to the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase. 
All primers were validated according to the protocol and standard curves were all within the 
tolerable range.
Leukocytes:
The right middle lung lobe was fixed in 4% buffered formalin solution overnight at room tem-
perature, dehydrated and embedded in paraplast (Amstelstad, Amsterdam, The Netherlands). 
Sections of 4 μm-thicknesses were used. The enzyme activity of leukocytes was visualized by 
enzyme histochemistry using chloracetatesterase staining (Leder staining). Leukocytes were 
counted manually (20 fields per mouse), and after automated correction for air/tissue ratio, the 
number of leukocytes/μm2 was calculated.
Statistical Analysis:
Data are expressed as mean (SD) when distributed normally (leukocyte counts, relative mRNA 
expression) and expressed as Box (median, 25th, 75 percentile) and Whiskers (range) otherwise 
(cytokine concentrations). Statistical analysis was performed with SAS (SAS Institute Inc. Cary 
NC, USA, version 8.02) statistical procedures. Since cytokine concentrations are not normally 
distributed, Kruskal Wallis procedures were used, with post hoc comparisons of subgroups 
(Duncan). For the analysis of normally distributed data (leukocyte counts and relative mRNA 
expression) ANOVA was used with post hoc comparison of group means (Duncan). Two-tailed 
P-values are reported and the level of significance was set to P < 0.05.
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resuLts
Inflammatory response after mechanical ventilation: role for TRIF:
LUNGS: In WT mice, MV increased levels of IL-1a, IL-1b and KC (figure 1), which is in line with 
previous data from our lab.7;8 In contrast, in TRIF mutant mice MV elicited only a minor increase 
in IL-1b and KC. Levels of IL-1a after MV were not different between WT and TRIF mutant mice 
(figure 1). In addition MV increased the messenger RNA expression of IL-1b in WT mice, but not 
in TRIF mutant mice following MV, indicating that TRIF affects IL-1b transcription (figure 2). NF-kB 
activity after MV was significantly lower in TRIF mutant mice compared with WT mice (figure 3).
Figure 1: Cytokine levels in lung homogenates.
Levels of interleukin (IL)-1a, IL-1β, tumor necrosis factor-a, IL-6, keratinocyte-derived chemokine (KC), 
and IL-10 in unventilated (C) and ventilated (V) wild type (WT) and TRIF mutant (TRIF) mice (panels A-F). 
Mechanical Ventilation in WT mice (group V-WT) increased IL-1a (P = 0.03), IL-1b (P < 0.0001) and KC (P < 
0.0001) in lung tissue homogenates when compared with unventilated WT mice (group C-WT). Mechanical 
ventilation in TRIF mutant mice (group V-TRIF) increased levels of IL-1a (P = 0.01), IL-1b (P = 0.0004) and 
KC (P < 0.0001) in lung tissue homogenates when compared with unventilated TRIF mutant mice (group 
C-TRIF). Ventilated TRIF mutant mice (V-TRIF) showed significantly lower levels of IL-1b (P = 0.01) and KC (P 
= 0.01) in lung homogenates following mechanical ventilation compared with ventilated WT mice (group 
V-WT). Data are expressed as Box (median, 25th, 75 percentile) and Whiskers (range). * = P < 0.05 compared 
with unventilated mice. + = P < 0.05 compared with ventilated WT mice (V-WT). - = lower detection limit.
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MV resulted in a pulmonary leukocyte influx in both WT and TRIF mutant mice (figure 4).
PLASMA: In WT mice, MV increased levels of IL-6 and KC in plasma (figure 5). In TRIF mutant 
mice, no increase of IL-6 was found after MV and the increase in KC appeared less pronounced.
Figure 2: Pro-IL-1β levels in lung tissue.
Pro-IL-1β messenger RNA levels in unventilated (C) and ventilated (V) wild type (WT) and TRIF mutant 
(TRIF) mice. Mechanical Ventilation in WT mice (group V-WT) increased pro-IL-1b mRNA (P < 0.0001) in 
lung tissue when compared with unventilated WT mice (group C-WT). In TRIF mutant mice no increase 
in mRNA expression of IL-1b was found following mechanical ventilation. Ventilated TRIF mutant mice 
(V-TRIF) showed significantly lower levels of pro-IL-1b (P < 0.0001) in lung tissue following mechanical 
ventilation compared with ventilated WT mice (group V-WT). Data are expressed as mean (SD) . 
* = P < 0.05 compared with unventilated mice. + = P < 0.05 compared with ventilated WT mice (V-WT). 
Figure 3: NFkB activity in lung tissue.
NFkB activity in lung tissue of ventilated (V) wild type (WT) and TRIF mutant (TRIF) mice. In ventilated TRIF 
mutant mice (group V-TRIF) NFkB activity was significantly lower (P < 0.0001) compared with ventilated 
WT mice (group V-WT). Data are expressed as optical densities from electrophoretic mobility shift assay 
analysis. + = P < 0.05 compared with ventilated WT mice (V-WT).
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Figure 4: Leukocyte counts.
Mechanical ventilation resulted in a pulmonary leukocyte influx in WT mice (group V-WT) (P < 0.0001) 
compared with unventilated WT mice (group C-WT). In TRIF mutant mice (group V-TRIF) mechanical 
ventilation also increased pulmonary leukocyte counts (P < 0.0001) compared with unventilated WT mice 
(group C-WT). The pulmonary leukocyte number in ventilated TRIF mutant mice appeared lower compared 
with ventilated WT mice (group V-WT), however this did not reach statistical significance (P = 0.07).
Figure 5: Cytokine levels in plasma.
Levels of interleukin (IL)-6, keratinocyte-derived chemokine (KC), IL-10 and tumor necrosis factor-a in 
unventilated (C) and ventilated (V) wild type (WT) and TRIF mutant (TRIF) mice (panels A-D). Mechanical 
ventilation in WT mice (group V-WT) increased IL-6 (P = 0.0009), and KC (p < 0.0001) in plasma when 
compared with unventilated WT mice (group C-WT). In TRIF mutant mice (group V-TRIF) no increase in 
IL-6 was found following mechanical ventilation when compared with the unventilated TRIF mutant mice 
(group C-TRIF). Mechanical ventilation in TRIF mutant mice (group V-TRIF) did increase levels of KC (P < 
0.0001) when compared with unventilated TRIF mutant mice (group C-TRIF). This was not statistically 
different from ventilated TRIF mutant mice (group V-TRIF). Data are expressed as Box (median, 25th, 75 
percentile) and Whiskers (range). * = P < 0.05 compared with unventilated mice. - = lower detection limit.
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Cardiopulmonary physiology:
The animals with an intraarterial canula exhibited stable hemodynamic variables throughout 
the experiments. Mean arterial pressure was within normal limits and remained above 65 
mmHg in all animals, which was in line with previous data from our lab.7 Blood gas analysis 
showed pH: 7.30 ± 0.07 in WT mice and 7.32 ± 0.08 in TRIF mutant mice; arterial oxygen tension: 
146 ± 23 mmHg in WT mice and 157 ± 20 mmHg in TRIF mutant mice; arterial carbon dioxide 
tension: 41 ± 6 mmHg in WT mice and 39 ± 5 mmHg in TRIF mutant mice; bicarbonate: 17.4 ± 3 
mmol/l in WT mice and 19.1 ± 3.1 mmol/l in TRIF mutant mice. PaO2 / FiO2 ratio’s and alveolar-
arterial oxygen gradients were not different between WT and TRIF mutant mice after MV.
dIsCussIon
The present study confirms earlier observations from our laboratory,7;8 and others,1;6;16 that 
MV using clinical relevant ventilator settings results in a pulmonary and systemic inflammatory 
response. The present study extends these findings by showing that TRIF deficiency attenu-
ates this inflammatory response following MV, by reducing NF-kB activation. TRIF deletion 
prevented pulmonary pro-IL-1β increase and systemic IL-6 increase after 4 hours of MV. Also, 
pulmonary levels of IL-1b and KC were significantly lower in TRIF deleted mice lungs compared 
with WT lungs after MV.
The TRIF pathway is a downstream pathway of TLR4 and TLR3,9;10 that can cause delayed NF-kB 
activation.17 Recently, we have shown the involvement of TLR4 in MV-induced inflammation.8 
The present study extends these findings by showing the involvement of TRIF signaling. We 
found that the MV-induced increase of KC and IL-1β was TRIF dependent. Since TRIF is also 
involved in the downstream signaling of TLR3 we cannot exclude the involvement of TLR3 in 
our model. However the results presented here closely resemble the results from our previous 
TLR4 experiment.8 Therefore it is likely that in downstream signaling of TLR4 the TRIF pathway 
is involved in the inflammatory response following MV. Subsequent studies using TLR3 deleted 
mice are needed to confirm the importance of TLR4 in MV-induced inflammation.
Potential relevance of findings:
Several studies have pointed out the involvement of the analyzed cytokines in lung injury. 
IL-1b has been shown to be among the most biologically active cytokines in the lungs,18;19 and 
therefore is proposed to play an important role in the pathogenesis of lung injury.20 In clinical 
studies, high tidal volume MV results in persistently high plasma levels of IL-1b, which is associ-
ated with distal organ failure and mortality.2;21 In the present study, TRIF deletion prevented 
IL-1β increase at messenger RNA level and attenuated the increase of IL-1β at protein levels 
indicating TRIF involvement at the level of transcription. This is interesting as it indicates major 
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involvement of the TRIF pathway and may indicate only minor or no influence of the MyD88 
pathway. However this hypothesis needs further investigation.
KC is a chemoattractant, but also has a direct cytotoxic effect.22 Jiang et al.23 found KC to 
be produced by pulmonary epithelial cells in a TLR4 dependent manner in direct response to 
bleomycin. More recently, functional TLR4 expression was found to be critical in the KC increase 
following hemorrhage.24 The present study shows that the increase of KC following MV is at 
least partly TRIF dependent.
Our data show that blocking TRIF dependent pathway prevents the increase in plasma IL-6 
after MV. Several studies suggest that Il-6 plays a role in the development of distal organ failure 
in ventilator-induced lung injury.2;25 Accordingly, TRIF modulation may attenuate distal organ 
failure induced by MV.
It should be noticed that in our model no evidence of either pulmonary dysfunction or 
distant organ failure was found, despite the development of an inflammatory response. Appar-
ently, the trigger induced by the ventilator is relatively mild and the lung is able to cope with 
the MV-induced inflammatory reaction. This has been demonstrated before in a study from our 
laboratory,7 and by a clinical study showing that 2 hours of MV in healthy children resulted in 
enhanced cytokine concentrations without clinical signs of pulmonary dysfunction.16 In acid-
induced lung injury TRIF deletion indeed diminished impairments in lung function.5 Therefore, 
the inflammatory response following MV in healthy lungs may be too subtle to identify changes 
in cardiopulmonary physiology. However, the inflammatory response following MV is clinically 
relevant as this forms the basis for the two-hit hypothesis proposing that injury (e.g., the criti-
cally ill patient) primes the immune system (“first hit”) for a lethal inflammatory reaction to a 
later, otherwise nonlethal, secondary insult (second hit), namely MV.26-28 This enhanced host 
response can lead to distal organ failure and is previously linked to TLR4 reactivity,29 which 
is interesting as we have shown that TLR4 is involved in the inflammatory response follow-
ing MV in healthy lungs.8 Downstream of TLR4 we identified the involvement of TRIF in this 
response. Therefore, inhibition of TRIF may be an effective strategy to prevent or attenuate MV 
induced pulmonary and systemic inflammation. Figure 6 shows a schematic overview of the 
downstream signaling pathways of TLR4.
KC is a major chemoattractant for leukocytes.30 In a previous study, we have shown that 4 
hours of MV in healthy mice induces a TLR4 dependent pulmonary leukocyte influx following 
the increase of KC in the lung.7;8 In the present study this pulmonary leukocyte influx is con-
firmed. In TRIF mutant mice leukocyte influx appeared less pronounced, however this did not 
reach statistical significance. This might be explained by the fact that in plasma, the increase in 
KC in TRIF mutant mice also appeared to be reduced, without reaching statistical significance.
Our study has several limitations. First, all studies were performed in mice. It is unknown 
whether the response to MV in mice is similar to the response in humans. Second, only the 
effect of 4 hours of MV was tested. In a previous study we have shown that the proinflam-
matory response is activated within 30 minutes after initiation of MV and intensifies up to 4 
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hours after initiation of MV.7 Preliminary observations show that the inflammatory response 
unaltered after 8 hours of MV compared with 4 hours of MV. Third, in the present study we did 
not evaluate the effect of different ventilatory modes. Interstingly, recent studies indicate that 
spontaneous ventilatory efforts may improve respiratory function such as diaphragm function, 
pulmonary gas exchange and hemodynamics following MV.31;32
Factors other than MV, possibly affecting TRIF were carefully avoided. Contamination with 
lipopolysaccharide is suggested to be a confounding factor in many studies.33 We therefore 
Figure 6: Downstream signaling of Toll-like receptor 4.
Schematic representation of downstream signaling pathways of the Toll-like receptor 4. Two pathways 
are involved. The rapid MyD88 dependent response and the delayed Toll/interleukin-1 receptor domain-
containing adapter inducing interferon-b (TRIF) response also known as the MyD88 independent 
response. Both signaling routes cause translocation of nuclear factor (NF)-κB into the nucleus, and 
transcription of proinflammatory genes inducing cytokine production. Our challenging hypothesis is that 
these cytokines induce a pro-inflammatory response, which can result in ventilator induced lung injury 
and distal organ injury. It should be noticed that activation of TLR3 may also activate TRIF dependent 
pathway (not shown in figure). 
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excluded lipopolysaccharide contamination during the experiments. The possibility of trigger-
ing an inflammatory response by invasive procedures (i.e. insertion of an intraarterial line),34 
was eliminated by performing experiments in non-invasively monitored animals. Previously 
cardiopulmonary stability in invasively monitored animals has been documented.7 In the 
present study mice were slightly acidotic following MV. As hypercapnic acidosis attenuates 
MV-induced inflammation in healthy mice,35 this could affect our results. However it is unlikely 
that the slight metabolic acidosis in the present study significantly affects our data. Indeed, cor-
recting metabolic acidosis does not alter levels of cytokines following MV in healthy mice.36 The 
possible immune modulating effects of anesthetics have been studied extensively.37 Ketamine, 
for instance, is known to have an inhibitory effect on lipopolysaccharide-induced cytokine pro-
duction,38-41 possibly by suppressing TLR4 expression.42 Recently, it has been demonstrated that 
ketamine alone (without lipopolysaccharide) also attenuated cytokine production in humans 
in the direct postoperative period after elective abdominal surgery.43 In the present study all 
animals received ketamine. Ideally, an additional control group of spontaneously breathing 
animals under ketamine, medetomidine and atropine anesthesia is needed. However, this will 
result in hypoventilation with severe respiratory acidosis and hemodynamic instability.
The current study supports a role for TRIF in the inflammatory reaction following MV in healthy 
lungs. Increasing the understanding of the innate immune response to MV and the contribu-
tion of MV to the “multiple hit” concept may lead to future treatment advances in VILI, in which 
TRIF may serve as a therapeutic target.
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Chapter 5
Hypercapnic acidosis attenuates the pulmonary 
innate immune response in ventilated healthy mice.
Feico J.J. Halbertsma, Michiel Vaneker, Peter Pickkers, Dirk G. Snijdelaar, 
Jan van Egmond, Gert Jan Scheffer, Johannes G. van der Hoeven.
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abstraCt
Background:
Mechanical ventilation (MV) with small tidal volumes reduces the development of Ventilator 
Induced Lung Injury (VILI) and mortality, but may increase PaCO2. It is not clear whether the 
beneficial effect of a lung-protective strategy results from reduced ventilation pressures/tidal 
volumes or is mediated by the effects of hypercapnic acidosis on the inflammatory response 
involved in the pathogenesis of VILI. To analyze whether hypercapnic acidosis affects lung tis-
sue cytokine levels and leukocyte influx healthy mice were ventilated.
Methods:
Healthy C57BL6 mice (n=40) were mechanically ventilated. Analysis of lung tissue and plasma 
concentrations of IL-1β, TNF-α, IL-6, IL-10 and keratocyte-derived chemokine (KC) after 2 hours of 
mechanical ventilation (Vt 8 ml/kg, PEEP 4 cmH2O) with 0.06% CO2 (room air), 2% CO2 or 4% CO2.
Results:
PaCO2 and pH were within normal range when ventilated with 0.06% CO2 and significantly 
changed with 2% and 4% CO2: (mean±SD) pH 7.23±0.06 and 7.15±0.04, PaCO2 7.9±1.4 and 
10.8±0.7 kPa, respectively (p<0.005). Blood pressure remained within normal limits in all animals. 
Quantitative microscopic analysis showed a 4.7±3.7 fold increase (p<0.01) in pulmonary leuko-
cyte influx in normocapnic ventilated animals and a significant reduction in leukocyte influx 
of 57±32% (p<0.01) and 67±22% (p<0.01) when ventilated with 2% and 4% CO2, respectively. 
Normocapnic ventilation induced a significant elevation of lung tissue IL-1β (1516±119 ng/ml), 
TNF-α (344±88 ng/ml), IL-6 (6310±807 ng/ml), IL-10 (995±152 ng/ml) and KC (36966±15294 
ng/ml) (all p-values <0.01). Hypercapnic acidosis with 2% resp. 4% CO2 significantly attenuated 
this increase with 25±32% and 54±32% (IL-1β, p<0.01); 17±36% and 58±33% (TNF-α, p<0.02); 
22±34% and 89±6% (IL-6, p<0.01); 20±31% and 67±17% (IL-10, p<0.01) and 16±44% and 
45±30% (KC, p=0.07)
Conclusions:
Hypercapnic acidosis attenuates the mechanical ventilation-induced immune response 
independent from reduced tidal volumes/pressures and may protect the lung from Ventilator 
Induced Lung Injury.
Hypercapnic acidosis attenuates the inflammatory response following mechanical ventilation
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IntroduCtIon
Mechanical ventilation (MV) can induce or exacerbate lung injury through a process of baro-
volutrauma and inflammation, termed Ventilator Induced Lung Injury (VILI). Reducing tidal vol-
umes and peak pressures (”Lung Protective Ventilation”) not only results in both lower pulmo-
nary cytokine levels but also decreased lung injury and mortality.1-3 However, low tidal volume 
ventilation may result in an increase in PaCO2 (“permissive hypercapnia”). Severe hypercapnic 
acidosis is usually well tolerated,4;5 and several clinical studies even suggest a protective effect 
on various organs, including the ventilated lung.6-9 A retrospective multi-variate logistic regres-
sion analysis of the ARDS network trial suggests that hypercapnic acidosis may be protective in 
ARDS patients ventilated with high tidal volumes.10
Several mechanisms may explain the effect of hypercapnic acidosis on VILI. First, accepting 
a higher PaCO2 level allows the use of smaller tidal volumes and lower airway pressures, which 
has beneficial effects on VILI, as shown in several clinical trials.5-7 Second, hypercapnic acidosis 
has direct effects on lung perfusion, oxygenation and oxygen delivery. Both experimental and 
clinical studies have shown that hypercapnic acidosis increases tissue oxygen delivery, by shift-
ing the oxygen dissociation curve to the right and improving V/Q match.11-13 Third, an increase 
in PaCO2 may have a direct modulating effect on the inflammatory response. Some of these 
effects are probably protective, such as inhibition of xanthine oxidase and oxygen radical for-
mation,14 decreased NF-kB transcriptional activity,15 and decreased complement activation.16 
Other effects are potentially harmful, e.g. reduced neutrophil burst and superoxide forma-
tion,16 inhibition of NO synthases,17 and delayed apoptosis.18;19 The biochemical pathways on a 
cellular level include altered electrochemical membrane potentials, alterations in micro-tubuli 
assembly, lowered enzyme activity and altered gene transcription as reviewed by Kregenow.16
In the clinical setting it is difficult to establish which of the two variables, reduced tidal 
volume/pressure or hypercapnic acidosis, accounts for the observed improvement in out-
come. We conducted a series of experiments to establish the effect of hypercapnic acidosis 
on ventilation-induced pulmonary cytokine increase and leukocyte influx by administration of 
inhaled CO2, while maintaining identical ventilator settings. We show that hypercapnic acidosis 
significantly decreases lung leukocyte influx and cytokine release.
MaterIaL and MetHods
All experiments were approved by the Regional Animal Ethics Committee Nijmegen and per-
formed under the guidelines of the Dutch Council for Animal Care and the National Institutes 
of Health.
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Animals:
C57BL6 mice (n=40, Charles River, Sulzfeld, Germany), 10 - 12 weeks of age, with a weight rang-
ing from 23-28 g were used.
Mechanical ventilation in mice:
Anesthesia was induced and maintained with intraperitoneal administration of a combination 
of Ketamine, Medetomidine and Atropine (KMA) as reported before.20 Animals were orally 
intubated under direct vision with an endotracheal tube (0.82 mm ID, 1.1 mm OD, length 
25 mm). Subsequently, animals were connected to the ventilator (MiniVent®, Hugo Sachs 
Elektronik - Harvard apparatus, March-Hugstetten Germany). Tidal volume (Vt) was set at 8 
ml/kg, which is comparable with Vt during spontaneous ventilation in C57BL6 mice.21 All ani-
mals were ventilated with 4 cm H2O PEEP. Studies using broncho-alveolar lavage did not find 
increased cytokine levels with similar ventilatory settings, however, using tissue homogenate 
we previously demonstrated increased intracellular and tissue cytokine levels, without evoking 
histological changes.20;22-24 To avoid direct oxygen toxicity 25;26 the FiO2 was set at 0.4. Respira-
tory rate was set and fixed at 150/min to obtain normocapnia with 0.06% CO2 (room air). An 
intra-arterial carotid canula was inserted for continuous blood pressure monitoring and blood 
gas analysis at the end of the experiment. Throughout the experiment rectal temperature was 
monitored and maintained between 36.5o and 37.5o C using a heating pad.
Study groups:
In the first set of experiments, animals were randomly divided into 4 groups. Group I (n=6) was 
not ventilated, immediately sacrificed after induction of anesthesia and served as the control 
group. Group II (n=6) was ventilated with 0.06 % CO2. Group III (n=6) was ventilated with 2% 
CO2, and Group IV (n = 6) was ventilated with 4% CO2. Ventilator settings in Group II, III and IV 
were identical as described above.
In a second set of experiments we used the same protocol to measure pulmonary wet/dry 
ratios. These animals were ventilated as in group II (n=4), III (n=4) and IV (n=4). Four spontane-
ously breathing animals served as controls (n=4).
Material harvesting and preparation of lung tissue:
Mechanical ventilation lasted two hours in all groups, after which the mice were sacrificed by 
exsanguination. Blood was collected from the arterial line, centrifuged at 13,000 g (Eppendorf 
5415 C, Nethler-Hinz GmbH, Hamburg) for 2 minutes and the plasma was stored at -80°C. 
Immediately after exsanguination, the heart and lungs were carefully removed en block via 
midline sternotomy. The right middle lobe was fixed for light microscopy. The remaining lung 
tissue was homogenized for the determination of cytokine concentrations.
To assess pulmonary edema, wet/dry ratios of both lungs were used; ratios were calculated 
by measuring lung weight before and after heating for 24 hours in a stove at 40°C.
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Light microscopy:
For light microscopy the material was fixed in 4% buffered formalin solution overnight at room 
temperature, dehydrated and embedded in paraplast (Amstelstad, Amsterdam, The Nether-
lands). Sections of 4 μm-thickness were used for analysis. The enzyme activity of leukocytes 
was visualized by enzyme histochemistry using chloracetatesterase staining (Leder staining). 
Leukocytes were counted manually (20 fields per mouse), and after automated correction for 
air/tissue ratio, leukocytes/μm2 were calculated. The pathologist was blinded for the group and 
ventilation protocol.
Laboratory tests:
Levels of TNF-α, IL-6, IL-10, and Keratocyte-derived chemokine (KC) in lung homogenate 
were measured using Enzyme-Linked-Immunosorbent Assay (ELISA) (for TNF-α, IL-6 and IL10; 
CytoSet, BioSource, USA; for KC; ELISA-Kit, R&D, USA). IL-1β was assessed using specific radio-
immuno-assays (Nijmegen University, Netherlands), as described previously.20;27 Lower limit of 
detection for IL-1β was 40 pg/ml, for TNF-α 32 pg/ml, for IL-6 160 pg/ml, for IL-10 16 pg/ml and 
for KC 160 pg/ml.
Statistical analysis:
Data are expressed as mean (SD). If cytokine concentrations were below the detection limit, 
lower limits of detection were used for further calculations.
Comparison between groups was performed using one-way ANOVA. A p-value <0.05 was 
considered statistically significant. All tests and graphs were constructed using GraphPad Prism 
version 4.00 for Windows, GraphPad Software, San Diego California USA.
resuLts
Cardio respiratory parameters:
As illustrated in table 1, animals ventilated without supplemental CO2 (Group II) exhibited nor-
mal pH, PaO2 and PaCO2 at the end of experiment, comparable with values in spontaneously 
breathing mice. Increasing inspiratory CO2 (group III and group IV) resulted in a significantly 
elevated PaCO2 and a decrease in pH (p<0.05) (table I), whereas base excess did not differ 
Table 1: Arterial blood gas analysis.
pH PaO2 PaCO2 HCO3
- BE
0.06% CO2 7.36±0.06 28.9±10.4 5.0±0.9 20.5±1.2 -4.4±1.5
2% CO2 7.23±0.06* 27.2±4.9 7.9±1.4* 21.4±0.9 -4.5±1.2
4% CO2 7.15±0.04* 28.9±1.3 10.8±0.7* 22.7±1.8 -3.8±2.8
PaO2 ,PaCO2 in kPa;
* p<0.005 2, 4% CO2 vs. 0.06% CO2
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between groups. In all animals, invasive arterial blood pressure (IABP) remained within normal 
limits throughout the experiment and did not differ between groups (table II).
Table 2: Arterial blood pressure.
T=0.5 hr T=1 hr T=1.5 hr T= 2 hr
0.06% CO2 95.6±15.7 95.3±15.9 78.6±8.1 80.1±10.2
2% CO2 92.1±14.3 78.6±6.9 76.2±7.9 74.3±2.4
4% CO2 92.5±5.1 85±7.2 79.25±3.3 81.5±8.1
Arterial blood pressure in mmHg
Light microscopy:
Mechanical ventilation significantly increased lung leukocyte counts in animals ventilated with 
0.06% CO2 from 207±133 / mm
2 to 971±496 / mm2 (group I vs. group II, p<0.01). MV with 2% 
and 4% CO2 (group III and IV) attenuated the increase in leukocyte influx with 57±32% and 
67±22% (p<0.01), respectively (figure 1). No alveolar tissue disruption or other structural dam-
age was observed and all detected leukocytes remained within the lung interstitium.
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Fig 1: Leukocyte counts.
Effect of two hours normo- and hypercapnic mechanical ventilation on leukocyte counts in lung tissue, 
compared with unventilated control animals. *P<0.05; + p<0.05 0.06 CO2 vs 2% CO2 vs 4% CO2.
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Wet/dry ratio:
There were no significant differences in wet/dry ratios between the four groups (data not 
shown, all p>0.2).
Cytokine concentrations:
IL-1β, TNF-α, IL-6, IL-10 and KC lung tissue levels were significantly increased after 2 hours of 
normocapnic MV: IL-1β from 42±4 to 1516±119 pg/ml; TNF-α from 42±18 to 344±88 pg/ml; IL-6 
from 264±130 to 6310±807 pg/ml; IL-10 from 233±124 to 995±152 pg/ml; KC from 384±217 
to 36967±15294 pg/ml (all p-values<0.01). In group III (2% CO2) and group IV (4% CO2), hyper-
capnic MV significantly attenuated this increase in IL-1β with 25±32% and 54±32% (p=0.006); 
TNF-α 17±36% and 58±33% (p=0.019); IL-6 22±34% and 89±6% (p=0.001); IL-10 20±31% and 
67±17% (p=0.005) and KC 16±44% and 45±30% (p=0.07) (Fig 2).
dIsCussIon
In the present study we demonstrate that the ventilation-induced increase in leukocyte influx 
and pulmonary cytokines, a hallmark of VILI, is significantly attenuated in hypercapnic-acidotic 
animals ventilated with the same tidal volumes. Hypercapnic acidosis may represent an 
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Fig 2: Cytokine levels in lung homogenates
Effect of two hours normo- and hypercapnic mechanical ventilation on ventilation-induced lung tissue 
cytokine release using identical ventilator settings. 
* P<0.05 vs. control; + p<0.05 0.06% CO2 vs 2% CO2 vs 4% CO2.
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important pathway to protect the lung against VILI. To our knowledge, this study demonstrates 
for the first time the attenuating effect of hypercapnic acidosis on cytokine levels in vivo. As 
all other cardiorespiratory and ventilatory parameters remained identical between ventilated 
groups, we assume that the observed differences are entirely attributable to differences in 
hypercapnic acidosis.
Our in vivo findings are in concordance with several in vitro observations. Lang et al.28 showed 
that hypercapnia attenuates TNF-α production in lipopolysaccharide (LPS)-stimulated rabbit 
and rat alveolar macrophages in vitro. In human LPS-stimulated polymorphonuclear neutroph-
lis and alveolar macrophages hypercapnic acidosis decreased the production of IL-8.15;29 IL-8 
is a potent chemoattractant and comparable with KC in animals. We showed an attenuated 
increase in KC during ventilation with hypercapnic acidosis. We previously demonstrated that 
mice ventilated for 30 minutes with identical ventilator settings had increased KC levels in 
lung homogenate prior to leukocyte influx, and that leukocyte depleted mice demonstrated 
a significant mechanical ventilation-induced increase in KC but hardly any increase in IL-1β, 
TNF-α, IL-6 and IL-10.20 The attenuated KC increase during hypercapnic acidosis may explain 
the decrease in leukocyte infiltration as observed by us and by others studying non-ventilation 
related primary lung injury (pulmonary LPS installation) and secondary lung injury (ischemia 
reperfusion) in vivo.30-32
Once cytokine up-regulation and leukocyte chemotaxis are triggered by mechanical 
ventilation, further propagation of the inflammatory response by release of cytokines from 
leukocytes through positive feedback occurs. Experimental administration of a IL-1β recep-
tor antagonist and TNF-α monoclonal antibodies appear to attenuate the development of 
VILI, demonstrating the involvement of cytokines in its pathogenesis.33-35 Moreover, several 
clinical studies clearly demonstrated the relation between cytokine levels and morbidity.36;37 
Another cytokine-propagating mechanism affected by hypercapnic acidosis may be decreased 
NF-κB activation. NF-κB appears to be stimulated by both IL-1β and TNF-α and regulates gene 
transcription responsible for IL-6 and KC synthesis.38 Hypercapnic acidosis inhibits NF-κB trans-
location into the nucleus by suppressing degradation of IκB-α, a regulatory protein that binds 
the cytoplasmatic inactive NF-κB.15;39 This pathway may offer an explanation for the reported 
attenuation of NF-κB mediated IL-6 and KC increase in hypercapnic acidosis. Further experi-
ments are necessary to elucidate what the effects of hypercapnic acidosis during MV are on the 
cellular mechanisms proposed above.
From our experiment it remains unclear whether it is the hypercapnic acidosis or the 
resultant acidosis that is responsible for the observed beneficial effects. In ex vivo lung injury 
experiments hypercapnic acidosis appears to preserve alveolo-capillary integrity more than 
metabolic acidosis.40 Also, synergistic effects between PaCO2 and pH may occur, as buffer ther-
apy for hypercapnic acidosis reduces its protective effects.40 A limitation of our study model is 
that the ventilator setting, although clinically relevant, results in functional dysregulation with 
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elevated cellular and tissue cytokine levels, but not in histological lung injury.20 Therefore, our 
study does not enable us to conclude that hypercapnic acidosis also better preserves pulmo-
nary integrity. However, the conclusions regarding the pathophysiological importance of the 
increased cytokine levels still hold. As ventilation duration in our study was limited to two hours, 
the observed beneficial effects can not directly be extrapolated to outcome when ventilated 
for longer periods. Also, whether hypercapnic acidosis also attenuates the cytokine response 
in an injured lung with an otherwise activated innate immune response as encountered in the 
clinical setting, needs further study.
In conclusion, hypercapnic acidosis by itself directly attenuates pulmonary leukocyte influx 
and cytokine release during mechanical ventilation, an effect that is independent from reduced 
tidal volume and pulmonary pressures. The observation that hypercapnic acidosis directly 
modulates the mechanical ventilation-induced innate immune response in the lung suggests 
that this pathway may account for the beneficial effects of hypercapnic acidosis in critically ill 
ventilated patients. The net effect of hypercapnic acidosis on pulmonary and other end organ 
function in the clinical setting remains to be determined.
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Isoflurane attenuates pulmonary IL-1β and 
systemic tnf-α following mechanical ventilation 
in healthy mice.
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abstraCt
Background:
Mechanical Ventilation (MV) induces an inflammatory response in healthy lungs. The resulting 
pro-inflammatory state is a risk factor for ventilator-induced lung injury and peripheral organ 
dysfunction. Isoflurane is known to have protective immunological effects on different organ 
systems. We tested the hypothesis that the MV-induced inflammatory response in healthy 
lungs is reduced by isoflurane.
Methods:
Healthy C57BL6 mice (n=34) were mechanically ventilated (tidal volume, 8 ml/kg; positive 
end-expiratory pressure, 4 cm H2O; fraction of inspired oxygen, 0.4) for 4 hours under general 
anesthesia using a mix of ketamine, medetomidine and atropine (KMA). Animals were divided 
into 4 groups: 1] Unventilated control group. 2] MV group using KMA anesthesia. 3] MV group 
using KMA with 0.25 MAC isoflurane. 4] MV group using KMA with 0.75 MAC isoflurane. Cyto-
kine levels were measured in lung homogenate and plasma. Leukocytes were counted in lung 
tissue.
Results:
Lung homogenates: MV increased pro-inflammatory cytokines in lung homogenate. In mice 
receiving KMA + isoflurane 0.75 MAC no significant increase in IL-1β was found compared with 
non-ventilated control mice.
Plasma: MV induced a systemic pro-inflammatory response. In mice anesthetized receiving 
KMA + isoflurane (both 0.25 MAC and 0.75 MAC) no significant increase in TNF-α was found 
compared with non-ventilated control mice.
Conclusions:
The present study is the first to show that isoflurane attenuates the pulmonary IL-1β and sys-
temic TNF-α response following mechanical ventilation in healthy mice.
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IntroduCtIon
Mechanical ventilation (MV) activates the innate immune system resulting in the release of 
cytokines,1 which may cause lung injury.2 This has been called Ventilator-Induced Lung Injury 
(VILI) and can develop into Acute Respiratory Distress Syndrome (ARDS), with a mortality rate 
in humans exceeding 40%.3 Ventilator settings play an important role since using a lung protec-
tive ventilation strategy (low tidal volumes) is associated with lower incidence of ARDS.4;5 The 
pathophysiology of VILI is poorly understood, but a role for pro-inflammatory pathways has 
been proposed.6
Previously, VILI has been studied in rodents using MV with tidal volume well beyond used 
in clinical practice (i.e>25 ml/kg).7;8 In addition, most studies were performed in animals with 
pre-injured lungs,9-11 limiting the clinical relevance of these models. Recently, data from our 
group showed that MV in healthy mice, using low tidal volumes (8 ml/kg) induces transient 
pulmonary and systemic inflammation.12 In addition, Wolthuis et al.13 showed that low tidal 
volume MV (6 ml/kg) increases plasma concentration of IL-6 and IL-8 in humans. Therefore, 
even protective MV induces a systemic inflammatory response in both mice and humans. As 
inflammation is associated with lung injury,4 and peripheral organ dysfunction,14 strategies to 
reduce MV-induced inflammation may appear of clinical relevance.
Isoflurane is widely used in general anesthesia and has profound protective immunological 
effects on the heart,15 the brain,16 and the kidneys.17 Surprisingly, the effects of isoflurane on 
MV-induced pulmonary and systemic inflammation in healthy lungs has not been studied. 
Therefore, we hypothesized that isoflurane reduces MV-induced pulmonary and systemic 
inflammation. In order to test this hypothesis healthy mice were mechanically ventilated for 4 
hours using a protective ventilation strategy.
MetHods
All experiments were approved by the Regional Animal Ethics Committee in Nijmegen and per-
formed under the guidelines of the Dutch Council for Animal Care and The National Institutes 
of Health.
Animals:
Experiments were carried out in male C57BL6 mice (n=34) (Charles River, Sulzfeld, Germany) 
age 10 - 12 weeks, with a weight ranging from 23 to 28g.
Mechanical ventilation:
Anesthesia was induced and maintained with an intraperitoneal injection of a combination of 
ketamine, medetomidine and atropine (KMA-mix) as described previously.12 Mice were orally 
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intubated and ventilated. In short, tidal volume was set at 8 ml/kg, frequency at 150 / min, 
PEEP at 4 cm H2O and the FiO2 at 0.4.
12 Throughout the experiment rectal temperature was 
monitored and maintained between 36ºC and 37.5ºC using a heating pad. In addition to the 
KMA-mix, assigned animals received an inspiratory isoflurane concentration of respectively 
0.3% and 1.0% which corresponds with MAC values of 0.25 and 0.75.18
Study groups:
Animals were randomly divided into 4 groups (n = 6 per group): 1] Control (C) (n=6): after induc-
tion of anesthesia, these mice were immediately sacrificed without being ventilated. 2] MV 
(V): animals were ventilated for 4 hours using KMA anesthesia. 3] MV with low dose isoflurane 
(V-I0.25): animals were ventilated for 4 hours using KMA anesthesia and 0.25 MAC isoflurane and 
4] MV with high dose isoflurane (V-I0.75): animals were ventilated for 4 hours using KMA and 
isoflurane 0.75 MAC anesthesia.
To assess the effect of 0.75 MAC isoflurane in addition to KMA on hemodynamic performance, 
pilot experiments were conducted. Two groups of mice (n = 5 per group) were mechanically 
ventilated in the presence of an intra-arterial catheter: I] four hours MV using KMA anesthesia, II] 
four hours of MV using KMA and isoflurane 0.75 MAC anesthesia. Continuous intraarterial carotid 
blood pressure was measured and arterial blood gas analysis was performed as described 
previously.12 We decided not to include these animals for cytokine or histopathologic analysis 
to avoid possible cytokine response resulting from instrumentation induced tissue damage. 
Furthermore as instrumentation may result in some blood loss and a considerable amount of 
blood was needed for blood gas analysis, the availability of blood for cytokine measurements 
would be insufficient.
Preparation and analysis of lung tissue:
After the animals were sacrificed, blood was collected by exsanguination, centrifuged at 14000 
rpm (13,000 g) (Eppendorf 5415 C, Nethler-Hinz GmbH, Hamburg) for 2 minutes and plasma 
was stored at -80°C. Immediately after exsanguination, heart and lungs were carefully removed 
en block via midline sternotomy. The right middle lobe was fixed for light microscopy. The 
remaining lung tissue was homogenized for determination of cytokine concentrations.
Levels of tumor necrosis factor (TNF)-a, interleukin (IL)-6, IL-10, and keratinocyte-derived 
chemokine (KC) in lung homogenate and plasma were measured using Enzyme-Linked 
Immunosorbent Assay (for TNF-a, IL-6 and IL10: CytoSet, BioSource, Camarillo California USA; 
for KC: ELISA-Kit, R&D systems, Minneapolis, Minnesota USA). Levels of IL-1a and IL-1b in lung 
homogenate and plasma were assessed using specific radio-immuno-assays developed in our 
laboratory.19 Lower detection limits: IL-1a and IL-1b; 40 pg/ml, TNF-a; 32 pg/ml, IL-6; 160 pg/ml, 
IL-10; 16 pg/ml and KC; 160 pg/ml.
For light microscopy the material was fixed in 4% buffered formalin solution overnight at 
room temperature, dehydrated and embedded in paraplast (Amstelstad, Amsterdam, The 
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Netherlands). Sections of 4 μm-thickness were used for further analysis. The enzyme activity 
of leukocytes was visualized by enzyme histochemistry using chloracetatesterase staining (a 
histochemical stain for granulocytes). The evaluating pathologist was blinded for the group to 
which the animal had been assigned.
Statistical Analysis:
Data are expressed as means (SEM) when distributed normally (mean arterial pressure, leuko-
cyte counts) and expressed as median (range) otherwise (cytokine concentrations). Statistical 
analysis was performed with SAS (SAS Institute Inc. Cary NC, USA) statistical procedures. Since 
cytokine concentrations are not normally distributed, Kruskal Wallis procedures were used, 
with post hoc comparisons of subgroups (Duncan). Data of a particular cytokine concentration 
variable were ranked, followed by ANOVA in the General Linear Models procedure using the 
MEANS procedure with the Duncan option and Bonferroni correction for multiple comparisons. 
For analysis of leukocyte counts ANOVA was used on non-ranked data with post hoc compari-
son of group means. The level of significance was set at P < 0.05.
resuLts
Cardiorespiratory parameters:
After initial reduction in mean arterial pressure (MAP), the animals exhibited stable hemody-
namic parameters throughout the course of the experiment (figure 1). No significant differences 
were found between mice receiving KMA and mice receiving KMA and isoflurane 0.75 MAC.
Blood gas analysis showed normal pH, arterial carbon dioxide tension (PaCO2) and arterial 
oxygen tension (PaO2) levels with a small decrease in base excess. Blood gas analysis after 4 
hours of MV was not significantly different between mice receiving KMA and mice receiving 
KMA and isoflurane 0.75 MAC (table 1).
Cytokine release induced by mechanical ventilation:
LUNG HOMOGENATES: In KMA anesthetized mice, MV induced a pulmonary pro-inflammatory 
response as indicated by elevated concentration of IL-1α, IL-1b,TNF-α and IL-6 compared with 
unventilated control mice. MV did not increase levels of IL-1b in mice receiving KMA + isoflurane 
0.75 MAC compared with unventilated control mice. Isoflurane did not affect the response of 
other measured cytokines (Figure 2).
PLASMA: In KMA anesthetized mice, MV induced a systemic pro-inflammatory response as 
indicated by elevated concentration of KC, IL-6 and TNF-α compared with unventilated control 
mice (figure 3). MV did not increase levels of TNF-α in mice receiving KMA + isoflurane (both 
0.25 MAC and 0.75 MAC) compared with unventilated control mice (figure 3). Isoflurane did not 
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affect the response of other measured cytokines. IL-1α and IL-1b remained below detection 
limit for all 4 groups (data not shown).
Histological examination:
MV was associated with significant elevation in the number of pulmonary leucocytes. Addition of 
isoflurane did not affect the number of pulmonary leukocytes following 4 hours of MV (table 2).
Figure 1: mean arterial pressure during
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Figure 1. Mean arterial pressure during mechanical ventilation. 
The animals with an intra-arterial cannula exhibited stable hemodynamic parameters throughout the 
experiments. Mean arterial pressure was within normal limits and remained above 65 mmHg in all 
animals. No differences were found between mice receiving KMA and mice receiving KMA with isoflurane 
0.75 MAC. Data are expressed as mean (SEM).
Table 1. Arterial blood gas analysis after 4 hours of mechanical ventilation in mice receiving KMA and KMA 
with 0.75 MAC isoflurane. 
Blood gas values
pH PaO2
(mmHg)
PaCO2
(mmHg)
HCO3
-
(mmol/l)
BE
I: KMA 7.35 (0.03) 194 (22) 36 (4) 19.6 (1.4) -6.3 (0.9)
II: KMA and isoflurane 0.75 MAC 7.38 (0.02) 188 (16) 32 (2) 19.9 (0.5) -5.7 (0.7)
Arterial blood gas analysis was only performed after 4 hours of mechanical ventilation. No samples were 
taken during mechanical ventilation, since this would result in hemodynamic instability due to excessive 
blood loss. No statistically significant differences were found between KMA and KMA with isoflurane 0.75 
MAC. Values are mean (SEM). BE = base excess. I = 4 hours MV using KMA anesthesia, II = 4 hours of MV 
using KMA and isoflurane 0.75 MAC anesthesia.
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Figure 2. Cytokine levels in lung homogenates. 
Mechanical ventilation significantly increased levels of interleukin (IL)-1a, IL-1b, IL-6, tumor necrosis 
factor-a and keratinocyte-derived chemokine in lung tissue homogenate when compared with 
unventilated animals (Group C). In mice receiving KMA + isoflurane 0.75 MAC mechanical ventilation did 
not increase IL-1b levels in lung homogenate compared with unventilated animals (Group C). Neither 
low-dose nor high-dose isoflurane did affect the response of other pro-inflammatory cytokines. Data 
are expressed as box (median, 25th and 75th percentiles) and whiskers (range). * P< 0.05 compared with 
unventilated animals (Group C); ** P<0.01 compared with unventilated animals (Group C). C = control 
group (unventilated mice); V = mice ventilated for 4 hours receiving KMA; V-I0.25 = mice ventilated for 4 
hours receiving KMA with 0.25 MAC Isoflurane; V-I0.75 = mice ventilated for 4 hours receiving KMA with 
0.75 MAC Isoflurane. - = lower detection limit.
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Figure 3. Cytokine levels in plasma. 
Mechanical ventilation significantly increased levels of keratinocyte-derived chemokine (KC), interleukin 
(IL)-6 and TNF-a in plasma when compared with unventilated animals (group C). In mice receiving KMA 
with isoflurane (both 0.25 MAC and 0.75 MAC) mechanical ventilation did not increase TNF-α levels in 
plasma compared with unventilated animals (Group C). Data are expressed as box (median, 25th and 75th 
percentiles) and whiskers (range). * P< 0.05 compared with unventilated animals (Group C); ** P<0.01 
compared with unventilated animals (Group C). C = control group (unventilated mice); V = mice ventilated 
for 4 hours receiving KMA; V-I0.25 = mice ventilated for 4 hours receiving KMA with 0.25 MAC Isoflurane; 
V-I0.75 = mice ventilated for 4 hours receiving KMA with 0.75 MAC Isoflurane. - = lower detection limit.
Table 2. Pulmonary leukocyte counts 
Groups Leukocytes x 10-4 / μm2
Mean (SD)
p-value
Control 3.2 (1.0)
Group V 6.1 (1.6) < 0.0001
Group V-I0.25 6.4 (1.7) < 0.0001
Group V-I0.75 7.6 (2.6) < 0.0001
Values are mean (SEM)
MV = mechanical ventilation
p-values compared with Control group (unventilated animals)
Between the ventilated groups no significant differences were found.
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dIsCussIon
The present study is the first to show that isoflurane attenuates the pulmonary IL-1β and sys-
temic TNF-α response induced by MV in healthy mice. These findings may be of clinical impor-
tance as inflammation is proposed to play a role in VILI and organ dysfunction in mechanically 
ventilated patients.4;14
Cytokine release induced by mechanical ventilation:
In line with previous work from our group,12 the present study confirms the pulmonary and 
systemic inflammatory response following 4 hours of low tidal volume MV in healthy lungs. 
Unlike inflammation following high tidal volume MV,5;20 little has been published about the 
effects of low tidal volume MV on pulmonary and systemic inflammation. Caruso et al.21 found 
an increase of IL-1b mRNA expression in lung tissue following low tidal volume MV. The present 
study extended this observation by showing increased IL-1b protein levels in lung homoge-
nates following low tidal volume MV. Recently, it has been shown that pulmonary inflammation 
was significantly lower when using a protective ventilatory strategy (low tidal volume, PEEP 10 
cmH2O) compared with a non protective strategy (high tidal volume with zero PEEP) after 5 
hours of MV in healthy lungs.13 Nevertheless, in that study and in line with our observations low 
tidal volume MV did increase levels of pro-inflammatory cytokines in broncho-alveolar lavage 
(BAL) fluid and plasma.13 In apparent contrast to our results are the findings of Dhanireddy et 
al.22 who did not find an increase of KC in lung homogenates and plasma following low tidal 
volume MV using isoflurane 4% and Takenaka et al.23 who also found no IL-6 and TNF-a increase 
in plasma following low tidal volume MV. However in both studies a trend towards an increase 
in pro-inflammatory cytokines could be observed. Accordingly, the present study confirms 
pulmonary and systemic cytokine increase following low tidal volume MV of healthy lungs.
Effect of isoflurane on inflammatory response:
Isoflurane attenuated the increase of pulmonary IL-1b and systemic TNF-a levels following 4 
hours of low tidal volume MV. Previously, isoflurane was found to inhibit IL-1b induced cytokine 
production of alveolar epithelial type II cells,24 which are widely exposed to isoflurane during 
general anesthesia.25 In injurious models, isoflurane is also found to reduce endotoxin induced 
lung injury,26 in which IL-1b and TNF-a are suggested to play an important role.27 In addition, 
isoflurane attenuated peritoneal fluid IL-1b response in zymosan-induced peritonitis.28 Further-
more isoflurane is found to reduce IL-1b in BAL fluid and IL-1b and TNF-a in plasma following 
endotoxemia.29
In apparent contrast to our findings, Kotani et al.30 found isoflurane to increase gene 
expression of IL-1b and TNF-a in BAL fluid following MV of healthy rats. Despite this increase 
in gene expression, no significant increase in cytokine concentrations in lung lavage fluid was 
reported.30
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In VILI various pro-inflammatory cytokines play a role including IL-1b and TNF-a. IL-1b has 
been shown to play a central role in lung injury following hemorrhage,31 or liver injury.32 as 
an early initiator of the inflammatory response. TNF-a is involved in pulmonary inflammation 
induced by high stretch MV in healthy lungs.7 Both IL-1b and TNF-a are involved in the inflam-
matory response to low tidal volume MV in healthy lungs.12;33 In the present study isoflurane 
prevented the increase of pulmonary IL-1b and systemic TNF-a levels following 4 hours of low 
tidal volume MV, therefore isoflurane may be of clinical importance in reducing VILI.
Methodological considerations:
The number of mice per group was chosen arbitrarily, based on our previous studies using this 
animal model.12;34 As the effect of isoflurane on mechanical ventilation-induced inflammation 
was unknown, we could not perform adequate sample size analysis. Therefore, data obtained 
from the present study should be interpreted with caution.
Factors affecting cytokine response other than MV were carefully avoided. Experiments were 
performed in non-invasively monitored animals, after having documented cardiorespiratory 
stability in invasively monitored animals to eliminate the possibility of triggering an inflamma-
tory response by insertion of an intra-arterial line.33 In the current study mean arterial pressure 
was maintained above 65 mmHg and blood gas analysis showed normal pH, PaCO2 and PaO2 
levels. Only a small decrease in base excess after 4 hours of MV was observed, comparable with 
other studies.7;35 This slight decrease in base excess in the presence of a normal mean arterial 
pressure unlikely interferes with our observations.
Ideally a subgroup receiving only isoflurane (without ketamine) and a subgroup with spon-
taneously breathing animals receiving KMA-anesthesia should be included. However, the latter 
subgroup will result in hypoventilation with severe respiratory acidosis and hemodynamic 
instability, and since ketamine is known to have an inhibitory effect on cytokine production,36;37 
this will make comparison with a subgroup receiving only isoflurane inappropriate.
It is now commonly accepted that MV as well as volatile anesthetics have profound immuno-
logical effects.38;39 Even low tidal volume MV leads to a pulmonary and systemic inflammatory 
response.12;33 In this respect isoflurane may play a role.
In conclusion, isoflurane attenuates the pulmonary IL-1β and systemic TNF-α increase following 
4 hours of low tidal volume MV in healthy mice.
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GeneraL dIsCussIon
Mechanical ventilation is a lifesaving intervention in the care of the critically ill patient. It is 
also used in millions of patients each week around the world to facilitate surgical interventions 
under general anesthesia. In the last 30 years numerous studies have provided evidence that 
lung injury is often associated with mechanical ventilation.1-3 This Ventilator Induced Lung 
Injury (VILI)  may impair the function of healthy lungs,4 or exacerbate injury in the diseased 
lung (i.e. due to infection, trauma).5
Clinical studies have shown that the inflammatory response in the lung depends on ventila-
tor settings. In patients with Acute Respiratory Distress Syndrome (ARDS) a “lung-protective” 
ventilation strategy attenuated inflammatory mediators,6 and decreased mortality.5 In these 
patients with severely injured lungs, it is extremely difficult to determine the specific contribu-
tion of mechanical ventilation to lung injury. In other words, whether mechanical ventilation per 
se induces pulmonary and systemic inflammation remains unknown. For a better understand-
ing of the relevant pathophysiologic mechanisms underlying the contribution of mechanical 
ventilation to the development of VILI, we developed a mouse model for prolonged mechanical 
ventilation, with ventilator settings similar to those used in clinical practice.
In chapter 2 it is shown that in our mouse model “noninjurious” or “lung-protective” ven-
tilation does not exist and that even this protective ventilation can lead to an inflammatory 
response in healthy lungs. Fortunately, mechanical ventilation in elective, healthy patients 
rarely leads to clinical relevant injury. Apparently, the trigger induced by the ventilator is 
relatively mild and the lung is able to cope with the inflammatory response. The inflamma-
tory changes observed in healthy lungs may just be physiologic adaptations to the artificial 
process of mechanical ventilation. However, the inflammatory response following mechanical 
ventilation may be clinically relevant as this forms the basis for the “two-hit hypothesis”. This 
proposes that injury (e.g., the critically ill patient) primes the immune system (“first hit”) for a 
lethal inflammatory reaction to a later, otherwise (usually) nonlethal, secondary insult (second 
hit), namely mechanical ventilation.7-9 This can result in full-blown ARDS with its high morbidity 
and mortality.5;10;11
Increasing evidence in rodents and in humans further support our findings of mechanical 
ventilation-induced inflammation in the absence of a priming pulmonary insult, even when 
applying currently considered “optimal” (least injurious) ventilator settings.12-14
The mechanisms underlying the inflammatory response following mechanical ventilation are 
incompletely understood. A role for pro-inflammatory pathways has been proposed.1 Toll-
like receptors (TLRs) are essential in host defense by starting an inflammatory response after 
recognizing pathogens in infectious lung injury.15 However recent studies indicate that TLRs 
(especially TLR4) also plays a role in non-infectious lung injury.16-19 In chapter 3 it is confirmed 
that in our mouse model TLR4 plays an important role in the inflammatory response induced 
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by mechanical ventilation in healthy lungs. Most likely, endogenous ligands for TLR4 initiate 
this process. Previously, different endogenous ligands for TLR4 have been identified including 
heat shock protein 60,20 fibronectin,21 heparan sulfate proteoglycan,22 biglycan,23 hyaluronan24 
and the myeloid-related proteins 8 and 14.25 Which endogenous ligands are responsible for 
activating TLR4 in the inflammatory response following mechanical ventilation in healthy lungs 
remains to be investigated.
To attenuate the inflammation induced by mechanical ventilation, TLR4 may be a useful 
therapeutic target. However, since TLR4 was first identified as the key identifier of lipopolysac-
charide, blocking this receptor will increase sensitivity to infection.26 We therefore investigated 
the pathway further downstream of TLR4, which is complex. TLR4 activation may stimulate 
two distinct post receptor pathways. First, a MyD88 pathway resulting in rapid translocation 
of nuclear factor (NF)-κB into the nucleus, and transcription of proinflammatory genes induc-
ing cytokine production.15;27 Second, a TRIF (Toll/interleukin-1 receptor domain-containing 
adapter inducing interferon-b) dependent pathway resulting in delayed NF-kB translocation. 
This pathway is also associated with enhanced cytokine production.27-29 Surprisingly, the TRIF 
pathway was recently found to mediate injury in the absence of an infectious agent.30 Given the 
fact that the MyD88 pathway is critical to the response to bacterial infections, new strategies 
to modulate the TRIF pathway while leaving the MyD88 pathway intact, might be beneficial in 
some forms of lung injury.27 Accordingly, we investigated TRIF involvement in our model of VILI. 
In chapter 4 it is shown that TRIF deletion prevented the increase in plasma IL-6 and attenuated 
pulmonary IL-1β levels following mechanical ventilation, by reducing NF-kB activation. IL-1b 
has been shown to be among the most biologically active cytokines in the lungs,31;32 and Il-6 
is associated with the development of distal organ failure in VILI.5;33 Therefore it is likely that in 
downstream signaling of TLR4, the TRIF pathway is involved and may be an effective strategy 
to prevent or reduce mechanical ventilation-induced pulmonary and systemic inflammation.
As mechanical ventilation-induced inflammation is associated with lung injury,5 and peripheral 
organ dysfunction,34 and persistent cytokine elevation is associated with a poor outcome in 
patients with ARDS,7;8 strategies to reduce mechanical ventilation-induced inflammation might 
be of clinical relevance. Low tidal volume mechanical ventilation was designed to protect the 
lungs from excessive stretch. Clinical trials indeed showed that ventilator management, by 
limiting tidal volume and by maintaining recruitment of alveolar regions with sufficient PEEP, 
can alter mortality in patients with ARDS.5;3515 These “lung-protective” mechanical ventilation 
strategies reduced but could not prevent VILI.4 However using low tidal volumes may result in 
an increase in PaCO2 (“permissive hypercapnia”). One can wonder if acceptance of hypercapnia 
with lung-protective ventilation should lead us to intentionally use hypercapnia in patients 
with acute lung injury. Several studies support this hypothesis. Hypercapnia has been shown 
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to reduce ventilator-induced lung injury,36;37 and to be remarkably well tolerated.38 It may even 
improve outcome in ARDS patients,38;39 possibly by attenuating inflammation.40 We therefore 
investigated the effects of hypercapnia on the inflammatory response following mechanical 
ventilation. In chapter 5 we demonstrate that hypercapnia attenuates mechanical ventilation-
induced inflammation. Following mechanical ventilation, hypercapnic acidosis by itself directly 
attenuated pulmonary leukocyte influx and cytokine release during mechanical ventilation 
while all other cardiorespiratory and ventilatory parameters remained identical between venti-
lated groups. Therefore, hypercapnic acidosis may represent an important pathway to protect 
the lung against VILI.
Isoflurane is widely used in general anesthesia and has profound protective immunological 
effects on the heart,41 the brain,42 and the kidneys.43 Studies of the pulmonary effects of 
isoflurane are limited to injurious models, in which isoflurane is found to reduce inflamma-
tion in endotoxin induced lung injury.44;45 Whether isoflurane can attenuate the inflammatory 
response in the healthy lung following mechanical ventilation is unknown. In chapter 6 it is 
shown that isoflurane indeed attenuates this inflammatory response induced by mechanical 
ventilation in healthy mice. Pulmonary IL-1β and systemic TNF-α levels during mechanical ven-
tilation were lower in the presence of inhaled isoflurane. Both IL-1b and TNF-a are important 
in the inflammatory response to low tidal volume mechanical ventilation in healthy lungs. 
Therefore, isoflurane may be of clinical importance in reducing VILI.
Future directions:
Studies in this thesis show that even a so-called protective mode of ventilation leads to an 
inflammatory response in healthy lungs. Fortunately, this inflammatory response is relatively 
mild and mostly of little clinical significance. Nevertheless, we investigated the effects of 
mechanical ventilation in healthy lungs to shed more light on the pathophysiological mecha-
nisms involved. The knowledge gained may help us understand its role in the two-hit scenario. 
It is clear that, from a clinical point of view, the next step should be to investigate this two-hit 
scenario, which more closely resembles the clinical situation in which critically ill patients are 
mechanically ventilated. Therefore in the future a ‘second hit’ model needs to be developed.
From a purely scientific point of view, human studies are needed to confirm the effects we 
found in mechanically ventilated healthy mice. From an ethical point of view it is difficult to 
mechanically ventilate healthy humans just for scientific reasons. Previously performed human 
studies have investigated mechanical ventilation in patients who underwent surgery. However, 
it is clear that in these studies the inflammatory effects of the surgical procedure cannot be 
excluded.
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To gain more insight in the pathophysiological mechanisms involved in mechanical ventila-
tion, several questions need to be addressed. First, a search “upstream” to identify the specific 
endogenous ligands which activate TLR4. Second, more research is needed to analyze the 
specific intracellular factors involved. Previously, TNF receptor associated factor 6 (TRAF 6) was 
found to mediate the delayed NF-kB activation initiated by TRIF.27;46 However, what other fac-
tors are involved and specifically, what key molecular “switch” controls activation of MyD88 or 
TRIF remains unclear. Besides factors initiating the inflammatory response little is known about 
stimuli that maintain the inflammatory response during prolonged mechanical ventilation.
In this thesis the influence of hypercapnia and the use of isoflurane were investigated.
From our experiments it remains unclear whether it is the hypercapnia or the resultant acidosis 
that is responsible for the observed beneficial effects. This needs further investigation.
Since isoflurane is so widely used in general anesthesia its protective pulmonary immunological 
effects need to be studied in humans. More research is clearly needed to identify new strategies 
in reducing the negative side effects of mechanical ventilation.
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suMMary
This thesis describes the effects of mechanical ventilation in healthy lungs. We developed an 
animal model suitable to study the inflammatory response following mechanical ventilation. 
Using this model, we investigated the pathophysiological mechanisms underlying Ventilator 
Induced Lung Injury (VILI) by analyzing the role of Toll-like receptor (TLR) signaling. We also 
examined possibilities of modifying the inflammatory response following mechanical ventila-
tion in the healthy lung.
Chapter 1 reviews the literature concerning VILI. Mechanical ventilation is an indispensable 
tool in the management of critically ill patients and during surgery under general anesthesia. 
Despite the life saving effect, mechanical ventilation can also exacerbate or perpetuate lung 
injury. Different theories on the underlying mechanism of VILI, clinical aspects of VILI and 
the contribution of different modes of mechanical ventilation are discussed. Higher levels 
of cytokines are associated with poorer clinical outcome. Stretching of pulmonary and non-
pulmonary cells by mechanical ventilation increases synthesis of cytokines, a process called 
mechanotransduction. Toll-like receptors (TLRs) form the core of our innate immune system 
by recognizing molecules that are broadly shared by pathogens. Recently, it was discovered 
that TLRs not only recognize exogenous microbial products, but also endogenous ligands. 
In the development of non-infectious lung injury TLR2 and TLR4 play an important role. The 
involvement of cytokines and the different TLRs in VILI are discussed. Finally, possibilities of 
modulating VILI are addressed. “Lung-protective” mechanical ventilation protects the lung from 
excessive stretch, which reduces but does not prevent VILI. Permissive hypercapnia and the use 
of isoflurane are described as possibilities of modulating VILI.
Chapter 2 describes the effects of mechanical ventilation in the healthy lung, using ventila-
tory protocols similar to those currently used clinically during general anesthesia and in the 
intensive care unit. Mechanical ventilation in healthy mice induces a reversible inflammatory 
reaction, while preserving tissue integrity. This model shows that “noninjurious” or “lung-
protective” ventilation may not exist and that even this careful mode of ventilation leads to a 
reversible inflammatory response. Furthermore this model offers opportunities to study the 
pathophysiological mechanisms of VILI and the contribution of mechanical ventilation to the 
“multiple-hit” concept.
Chapter 3 analyses the involvement of TLR2 and TLR4 receptor signaling in the inflammatory 
response induced by mechanical ventilation in the healthy lung. The results show that TLR2 
signaling does not play a role in the inflammatory response following mechanical ventila-
tion in healthy mice. Instead, several key findings regarding the role of TLR4 signaling are 
revealed. Mechanical ventilation resulted in elevated expression of endogenous TLR4 ligands 
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in broncho-alveolar lavage fluid and enhanced mRNA levels for TLR4 in lung homogenates. 
The increase of inflammatory cytokines in the lung and the systemic inflammatory response in 
plasma following mechanical ventilation appeared to be at least partially TLR4 dependent, sup-
porting a role for TLR4 in the inflammatory reaction following mechanical ventilation in healthy 
lungs. These are important findings, as they may provide guidance for therapeutic strategies.
Chapter 4 analyses the involvement of Toll/interleukin-1 receptor domain-containing adapter 
inducing interferon-b (TRIF), a protein downstream of TLR4. Activation of TRIF causes delayed 
translocation of nuclear factor (NF)-κB into the nucleus, and transcription of proinflammatory 
genes inducing cytokine production. The increase of inflammatory cytokines in the lung and 
the systemic inflammatory response in plasma following mechanical ventilation appeared at 
least partially TRIF dependent, since it was found that TRIF deficiency attenuated inflammation.
Chapter 5 analyzes the effect of hypercapnic acidosis on mechanical ventilation-induced 
inflammatory response. A series of experiments is described to establish the effect of hyper-
capnic acidosis on pulmonary cytokine increase and leukocyte influx by administration of 
inhaled CO2, while maintaining identical ventilator settings. Hypercapnic acidosis significantly 
decreases pulmonary leukocyte influx and cytokine release following mechanical ventilation.
Chapter 6 analyzes the effect of isoflurane on mechanical ventilation-induced inflammatory 
response. A series of experiments were performed in which mice were ventilated receiving 
different inspiratory concentrations of isoflurane to establish its effect on pulmonary cytokine 
increase and leukocyte influx following mechanical ventilation. Isoflurane attenuates the pul-
monary IL-1β and systemic TNF-α response induced by mechanical ventilation in healthy mice.
Chapter 9
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saMenVattInG
Dit proefschrift beschrijft de relatie tussen beademing en het ontstaan van een ontstekings-
reactie. Wij ontwikkelden een diermodel waarmee aangetoond werd dat kunstmatige 
beademing van gezonde longen een ontstekingsreactie genereert in de long zelf, maar ook 
in andere organen. Dit model maakt het mogelijk om onderzoek te doen naar onderliggende 
pathofysiologische mechanismen van beademings-geïnduceerde longschade en de rol van 
de Toll receptoren 2 en 4 daarbij. Tevens hebben we met dit model onderzoek gedaan naar 
mogelijkheden om deze ontstekingsreactie als gevolg van beademing te remmen. 
Kunstmatige beademing is levensreddend bij de behandeling van kritisch zieke patiënten met 
respiratoir falen en onmisbaar tijdens operaties onder algehele anesthesie. Echter, kunstmatige 
beademing kan reeds bestaande longschade verergeren of nieuwe longschade doen ontstaan. 
Ondanks het levensreddende effect heeft kunstmatige beademing dus ook ongewenste bij-
effecten. In hoofdstuk 1 wordt de bestaande literatuur aangaande beademings-geïnduceerde 
longschade samengevat. De verschillende theorieën over de onderliggende mechanismen 
van beademings-geïnduceerde longschade worden beschreven evenals de klinische aspec-
ten, waarbij ingegaan wordt op de bijdrage van de verschillende vormen van kunstmatige 
beademing.
Kunstmatige beademing stimuleert de aanmaak van ontstekingseiwitten als gevolg van 
rek op de long. Dit proces wordt mechanotransductie genoemd. Hogere concentraties van 
ontstekingseiwitten zijn geassocieerd met een slechtere prognose. De betrokkenheid van 
ontstekingseiwitten (onder andere cytokines en witte bloedlichaampjes) bij het ontstaan van 
beademings-geïnduceerde longschade wordt besproken. 
Toll receptoren vormen de basis van onze eerste afweer tegen ziekteverwekkers van buiten. 
Recent heeft men ontdekt dat deze receptoren niet alleen schadelijke lichaamsvreemde stof-
fen, maar ook lichaamseigen stoffen, zogenaamde endogene liganden kunnen herkennen. De 
betrokkenheid van Toll receptoren bij het ontstaan van longschade wordt besproken evenals 
het werkingsmechanisme van deze Toll receptoren daarbij. 
 Tot slot wordt een aantal mogelijkheden om beademings-geïnduceerde longschade te 
remmen beschreven. Kunstmatige beademing met kleine volumina beschermt de long tegen 
overmatige rek, hetgeen de longschade vermindert maar niet voorkomt. Hypercapnie, oftewel 
het opzettelijk hoog houden van het koolstofdioxide gehalte in het bloed, wordt gezien als 
mogelijke remmer van beademings-geïnduceerde longschade. Isofluraan is een dampvormig 
anesthesticum dat over de hele wereld gebruikt wordt bij kunstmatige beademing onder alge-
hele anesthesie. Het gebruik van isofluraan kan de ontwikkeling van beademingsgeïnduceerde 
longschade mogelijk remmen.
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Hoofdstuk 2 beschrijft de gevolgen van kunstmatige beademing in de gezonde long bij 
muizen, waarbij gebruik wordt gemaakt van beademingsinstellingen die vergelijkbaar zijn met 
de instellingen die gebruikt worden om patiënten op een operatiekamer of intensive care te 
beademen. Dit diermodel laat zien dat “niet schadelijke” of “longprotectieve” beademing niet 
bestaat en dat zelfs een voorzichtige manier van beademen leidt tot een ontstekingsreactie.
Hoofdstuk 3 analyseert de betrokkenheid van de Toll 2 en de Toll 4 receptor bij het ontstaan van 
de ontstekingsreactie als gevolg van kunstmatige beademing. De Toll 2 receptor blijkt geen rol 
te spelen bij het ontstaan van beademings-geïnduceerde longschade. Echter, een aantal zeer 
belangrijke bevindingen worden gedaan betreffende de Toll 4 receptor. Kunstmatige beade-
ming resulteerde in een verhoogde expressie van endogene liganden voor deze receptor. Ook 
bleek de gevonden stijging van ontstekingseiwitten in de long en in het bloed afhankelijk te 
zijn van de aanwezigheid van de Toll 4 receptor.
Hoofdstuk 4 analyseert de betrokkenheid van TRIF (Toll/interleukin-1 receptor domain-
containing adapter inducing interferon-b), een eiwit dat intracellulair als boodschapper fun-
geert na activatie van de Toll 4 receptor. De afwezigheid van TRIF verminderde de vorming van 
ontstekingseiwitten in de long en het bloed, hetgeen een belangrijke rol voor TRIF ondersteunt 
bij beademings-geïnduceerde longschade in gezonde longen.
Hoofdstuk 5 analyseert het effect van hypercapnie op beademings-geïnduceerde longschade 
in gezonde longen. Hypercapnie is een verhoogd koolstofdioxidegehalte in het bloed. Een 
reeks experimenten wordt beschreven om de effecten te onderzoeken van hypercapnie op de 
ontstekingseiwitten die ontstaan als gevolg van kunstmatige beademing. Hypercapnie blijkt 
een remmend effect te hebben op beademings-geïnduceerde longschade.
Hoofdstuk 6 analyseert het effect van isofluraan op beademings-geïnduceerde longschade. 
Isofluraan is een dampvormig anestheticum dat gebruikt wordt om iemand onder narcose te 
houden. Een reeks experimenten wordt beschreven om de effecten te onderzoeken van de 
inhalatie van isofluraan op de ontstekingseiwitten die ontstaan als gevolg van kunstmatige 
beademing. Isofluraan blijkt een remmend effect te hebben op beademings-geïnduceerde 
longschade.
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Het proefschrift is klaar! Het van meet af aan opzetten en valideren van een experimentele 
onderzoekslijn tijdens mijn opleiding tot medisch specialist bleek een gigantisch grote klus 
die gepaard ging met heel veel goede momenten en uiteraard soms ook met tegenslagen. 
Ik ben dan ook erg blij dat het proefschrift er ligt. Al met al een zeer leerzame en waardevolle 
periode in mijn carrière. Echter, dit zou niet gerealiseerd zijn zonder de hulp van velen. Ik wil 
allen die mij hebben bijgestaan bij de totstandkoming van dit proefschrift dan ook hartelijk 
bedanken. Velen hebben een bijdrage geleverd, maar het is helaas onmogelijk iedereen bij 
naam te noemen. Toch wil ik een aantal mensen in het bijzonder bedanken.
Geachte prof. dr. Scheffer, beste Gert Jan, jouw steun en vertrouwen in dit project waren 
essentieel. Je optimistische houding en enthousiasme hebben mij altijd gestimuleerd om 
het onderzoek voort te zetten. Inmiddels is het een goed lopende onderzoekstrein, waar we 
hopelijk nog lang de vruchten van zullen plukken. Hartelijk dank dat je mij de mogelijkheid gaf 
te promoveren. 
Geachte prof. dr. Van der Hoeven, beste Hans, je hebt veel structuur aangebracht in mijn wilde 
ideeën voor telkens nieuwe experimenten. Hartelijk dank voor je inhoudelijke bijdrage, de 
momenten van sturing en advies en je onuitputtelijke energie die aanstekelijk werkt. 
Dr. Snijdelaar, beste Dik, het moment dat jij erbij kwam als copromotor was een belangrijk 
moment, omdat het toen logistiek behoorlijk vast zat. Je nuchtere kijk en daadkracht zijn 
absoluut van onschatbare waarde geweest voor het slagen van dit promotieonderzoek en mijn 
opleiding tot medisch specialist. Daar ben ik je heel dankbaar voor.
Dr. Heunks, beste Leo, ook jij bent als copromotor van cruciaal belang geweest voor het slagen 
van dit promotieonderzoek. Zeker toen we op cellulair niveau unieke resultaten boekten en het 
allemaal behoorlijk ingewikkeld werd, stond je altijd voor mij klaar met hulp en adviezen ten 
aanzien van mijn ideeën. Je aanstekelijke enthousiasme maakte dat ik de druk op de ketel kon 
houden. Hartelijk dank daarvoor.
Dr. Joosten, beste Leo, je enthousiasme en betrokkenheid als copromotor bij dit onderzoek was 
essentieel. Van je kennis van de moleculaire biologie heb ik veel geleerd en kan ik nog steeds 
veel leren. Tijdens de laatste fase van dit proefschrift heb je mij enorm gestimuleerd om alles 
rond te krijgen. Hartelijk dank. 
Beste leden van de manuscriptcommissie: prof. dr. J.W.M. van der Meer, prof. dr. P.N.R. Dekhuijzen 
en prof. dr. A.B.J. Groeneveld, hartelijk dank voor het beoordelen van dit proefschrift. 
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Dr. Van Egmond, beste Jan, jij was er vanaf dag één bij betrokken. Ik heb grote bewondering 
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